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Abstract 
 
Frizzled 4 belongs to the superfamily of G protein coupled receptors. The 
unstructured cytosolic tail of the receptor is essential for the activation of 
different intracellular signalling pathway. Mutations in the fz4 gene are 
responsible for the Familial exudative vitreoretinopathy (FEVR), among these 
the autosomal dominant frameshift mutation L501fsX533 that codes for a new 
carboxy terminal tail. Here we show that the new tail generated by the 
frameshift mutation acquires a helix-loop-helix conformation. The helices are 
amphipathic, display affinity for membranes and resemble the structure of 
Influenza Hemagglutinin fusion peptide at the pH of fusion. Shape and 
curvature of the mutant tail is proven essential for proper membrane interaction 
in vitro. The new fold of the tail is necessary for the aggregation and retention 
in the Endoplasmic Reticulum of the receptor via its interaction with the 
membrane and is sufficient to induce  the misfolding and affect trafficking of a 
chimeric VSVG protein containing the mutated tail. Shifting the fold of the tail 
to a more disordered conformation relocates the receptor to the Plasma 
Membrane. Such disordered to ordered structural transition was never 
described in mammalian receptors and pinpoints the need to consider structural 
transition as possible outcome of mutations in unstructured regions of proteins.  
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1. Background  
 
1.1 Overview on the secretory pathway 
 
Eukaryotic cells are highly compartmentalised and each distinct membrane-
bound organelles has a unique composition of proteins and lipids. This feature 
is essential for several cellular processes. To sort molecules to defined 
locations are required highly specific transport mechanisms which also ensure 
that the identity, and hence the function, of individual compartments are 
maintained. Proteins carry structural informations that target them to their 
correct destination and many sorting signals have now been identified (Nakai 
2000). Proteins that are transported within the secretory pathway are either 
secreted from the cell, destined to the plasma membrane, addressed to 
lysosomes, or are retained as “residents” in any of the organelles (Michelsen et 
al. 2005). The endoplasmic reticulum (ER) controls the correct fold of  newly 
synthesised proteins, before being packaged into transport vesicles (Prydz et al. 
2008). Secretory proteins are then transported through the Golgi cisternae to 
the trans-Golgi network (TGN), or Golgi exit site (Beckers and Rothman 
1992). 
At the TGN proteins are sorted according to their final destinations. The TGN 
and the early endosomal compartment represent the two major sorting stations 
of the cell.  (De Matteis and Luini 2008). Proteins are internalised from the cell 
surface in endocytic vesicles and transported to the early endosomal 
compartment where sorting takes place. Thus, endocytosed proteins can then 
be recycled to the plasma membrane (such as recycling receptors), or 
transported to the TGN or to the lysosome via the late endosomes for 
degradation (Seaman 2007).  
Protein transport in the secretory and endocytic pathways is a multi-step 
process involving the generation of transport carriers, the shipment of the 
transport carriers between compartments, and the specific fusion of these 
transport carriers with a target membrane (Derby and Gleeson 2007). During 
the last twenty years, much of the cellular machinery responsible for 
intracellular transport and protein sorting has been described. It is now clear 
that several human diseases are due to defects of intracellular trafficking, 
pinpointing the biological importance of these accurate membrane-mediated 
processes (Amara et al. 1992; Aridor and Hannan 2000; van Vliet et al. 2003; 
Olkkonen and Ikonen 2006). 
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1.2 Visiting the ER  
 
The ER provides for the fold and assembly of plasma membrane receptors, ion 
channels, secreted hormones, catabolic and metabolic enzymes. A quality 
control (QC) machinery co-ordinates ER activities in accord with cell and 
organism demands [Fig. 1 (Dejgaard et al. 2004)]. 
As a consequence, protein assembly and folding in the ER concern a broad 
range of essential biological process. Specific mistakes in protein handling in 
the ER can cause the development of different and seemingly unrelated 
diseases affecting different organs (Olkkonen and Ikonen 2000; Olkkonen and 
Ikonen 2006).  
 
The first compartment of the secretory pathway is the ER (Aridor 2007), one of 
the largest intra-cellular organelles, responsible for more than 50% of the total 
membrane content in a secretory cell wherein takes up over 10% of a cell’s 
volume (Chevet et al. 2001). The elaborate architecture correlates with the role 
of the ER in a variety of cellular processes including assembly of proteins, 
folding, biosynthesis of lipids and control of Ca2+ signaling and homeostasis 
(Borgese et al. 2006). The elaborate activities of the ER are prone to mistakes 
that lead to development of diseases (Aridor and Balch 1999). 
Upon translation, proteins destined for residence along the secretory pathway 
are targeted by N-terminal signal to the ER lumen (Walter and Johnson 1994). 
These proteins are synthesized by ER-associated ribosomes and co-
translationally translocated across the membrane via interactions with the 
Sec61p complex and the signal recognition particle (SRP) receptor (Rapoport 
et al. 1996; Matlack et al. 1998). The polypeptide chain is cotranslationally 
translocated into the lumen of the ER through the Sec61p membrane channel, 
referred to as the translocon, with the assistance of the translocating-chain 
associating membrane (TRAM) protein (Gorlich and Rapoport 1993). The ER 
sorts proteins according their assembly and folding. Folded and assembled 
proteins are packeged in membrane carriers to be trasported to the Golgi 
complex via vescicles formation mediated by cytosolic protein complexes, the 
COPII coat (Barlowe et al. 1994; Aridor et al. 1998; Bi et al. 2002; Mancias 
and Goldberg 2008). Misfolded and unstructured proteins are diverted from a 
folding pathway to proteasome-mediated degradation (Fig. 1) (Hoff et al. 2004; 
Hebert et al. 2010). Proteins are retro-translocate in the cytosol for proteasome-
mediated degradation (Hiller et al. 1996; Pilon et al. 1997; Hebert et al. 2010). 
 
 
  
Figure 1. CNX/CRT cycle. (a) The precursor glycan 
(Glc3Man5-9GlcNAc2 ) linked to the lipid molecule, dolichol (Burda 
and Aebi, 1999). (b) Glucosidase I and II successively trim two of the 
glucose residues leaving the Glc1Man9GlcNAc2 core oligosaccharide. 
(c) Calnexin and its lumenal paralogue calreticulin are lectins that 
specifically bind monoglucosylated oligosaccharides, and present them 
to the glycoprotein-specific thiol oxidoreductase, ERp57, which also 
bound to CNX/CRT. If the proteins are correctly folded (d) they 
proceed further into the secretory pathway, whereas incompletely 
folded proteins (e) are recognized by UGGT. (f) UGGT reglucosylates 
incompletely folded proteins by readdition of a single glucose residue 
from UDP-Glc. (g) The CNX/CRT cycle continues until the proteins 
are correctly folded or directed to ER-associated degradation (ERAD) 
after trimming by ER !1,2-mannosidases. (h) An enzymatically 
inactive member of this protein family, ER Degradation Enhancing !-
Mannosidase-like protein (EDEM) and the yeast homologue Mn11p 
(mannosidase-like protein) or Htm 1p (homologous to mannosidase I, 
shown as HTM 1) may participate as lectins and promote ERAD of 
incorrectly folded proteins that are then transported to the cytosol via 
the Sec61p translocon complex where they are proteolytically degraded 
by the proteasome system, in most cases following polyubiquitination. 
Dejgaard et al. 2004 
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1.3 ER processing disease 
 
Mutations in proteins often hinders their proper folding and thus their activity. 
Generally, loss of function is caused by folding problems (Aridor 2007). 
The scenario is much more complicated because sometimes mutation does not 
alter the function of protein. Despite its activity, the fold of the mutant is still 
recognized by QC that traps it in the ER. Defect not altering the function of the 
protein but still causing its miss-localization are called conformational disease. 
A deletion of phenylalanine (F) at position 508 in cystic fibrosis 
transmembrane conductance regulator (CFTR) is the cause for disease in up to 
80% of cystic fibrosis patients. The deletion in the cytosolic portion of CFTR 
causes the absence from the plasma membranes of epithelial cells from patients 
with ΔF508 allele. Unlike wild-type CFTR, which is trasported  to the plasma 
membrane along the secretory pathway, ΔF508 is retained and degraded in a 
pre-Golgi compartment. These observations have led to the hypothesis that the 
ΔF508 mutation leads to misfolding of CFTR and causing retention of the 
misfolded protein by the QC in the ER, resulting in its rapid degradation by the 
ubiquitin-proteasome pathway (Ward et al. 1995). Loss of CFTR function 
alters the hydration of the mucosal layer that lines the airway epithelia leading 
to persistent bacterial growth and development of lung fibrosis (Moskowitz et 
al. 2008). 
When a protein fails to fold, recognition for export from the ER is prevented 
and also degradation is inhibited leading to accumulation and possible 
aggregation (Thomas et al. 2004). These events can induce the inflammatory 
responses and can also culminate in cellular apoptotic response, eliminating 
affected cells to preserve organ function. This solution may cause  
degenerative disease leading to organ decay. Therefore in addition to loss of 
function derived from the retention of the mutant protein intracellularly, 
apoptosis is observed due to the inability of the ER to degrade the mutant 
protein (Aridor 2007). Alzheimer’s disease (AD) is a progressive 
neurodegenerative disorder characterized by a progressive decline in many 
cognitive processes that leads to dementia. Accumulation of β-amyloid plaques 
and neurofibrillary tangles are the well-known histopathological hallmarks of 
AD. It is recognized that increased production, oligomerization and 
aggregation of amyloid-β peptides are the crucial reasons of the onset of AD. 
The toxic amyloid-β peptides Aβ40 and Aβ42 are processed from the APP 
(amyloid-β precursor protein) via cleavage by BACE1 (β-secretase) and γ-
secretase complexes. APP is a transmembrane protein which is folded in the 
ER and transported through the Golgi complex to the plasma membrane, where 
APP can be endocytosed and trasported to the lysosomal compartment. Several 
studies have demonstrated that amyloid-β can be oligomerized and localized to 
intracellular compartments, in particular in AD, which can (i) alter the function 
of proteasomes and lysosomes, (ii) damage calcium homeostasis and (iii) 
enhance the formation of neurofibrillary tangles in neuron cells. Accumulation 
of unfolded or aggregated proteins, increased oxidative stress, and metabolic 
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disturbances are characteristic features of AD therefore it is clear that AD 
brains display many markers of ER stress. ER tries to defend the host by 
activating the UPR (unfolded protein response) including signaling pathways 
that recall the adaptive changes in metabolism and gene expression required to 
manage stress situations. If this condition becomes more prolonged or 
unbearable, the ER can then trigger the apoptotic programm killing the cell but 
saving the tissue from necrotic injury (Salminen et al. 2009). 
Variations on these conditions are observed in a number of seemingly 
unrelated degenerative and neurodegenerative diseases. ER-derived diseases 
also develop because of mutations in the machinery which senses, processes, 
exports or degrades proteins in the ER (Aridor 2007). 
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1.4 Quality control: the folding in the ER 
 
A number of chaperones in the lumen of the ER assists the protein to acquire 
its proper tertiary and quaternary structures (Chevet et al. 2001). They slow 
down folding and prevent aggregation, leading to the correct formation of 
disulphide bonds. The same chaperones are responsible for the identification of 
malformed proteins, sending them back through the translocon into the cytosol 
to be degraded by the proteosome (Lord et al. 2000).   
Guided by the primary information encoded in the polypeptide sequence, 
proteins inserted in the ER acquire the energetically stable conformation. 
Therefore, hydrophobic side chains are packed within the protein and intra-
molecular interactions, as ionic and disulphide bonds, are formed to stabilize a 
folded configuration and reduce the free energy associated with the newly 
sinthesized polypetide (Anfinsen and Haber 1961). Recent work has 
demostrated that stability of polypeptides in the chemical environment of the 
ER is sufficient for proteins to move forward in the secretory pathway 
(Sekijima et al. 2005). Soluble proteins are folded within the lumen of the ER 
whereas membrane proteins are folded in three environments; the cytosol of 
the cell, the lipid bilayer of the ER and the ER lumen. The basic chemical 
environment in the ER resembles that of the outside of the cell. ER lumen is 
oxidative and contains millimolar Ca2+ concentrations (Hwang et al. 1992; 
Schroder and Kaufman 2005). The lipid composition of the ER membrane also 
differs from that of the plasma membrane with low concentrations of 
cholesterol (Allan 1996). At the onset of the peptides traslocation, folding is 
guided by interactions with components of the folding chaperones. During 
synthesis, the traslocon pore permits the transfer of 70 amino acids, restricting 
the freedom of peptide folding during insertion within the ER (Matlack and 
Walter 1995; Ban et al. 2000). Once polypeptides emerge within the ER lumen 
are recognized and modified by the ER folding machinery and the signal 
peptide is removed. Oligosaccharyltransferase transfers high mannose 
oligosaccharides [Glc(3)Man(9)GlcNAc(2)] from dolicol linked precursors on 
the Asparagine residues within Asn-X-Ser sequences that extend from the 
translocon pore (Nilsson and von Heijne 1993). This reaction (N-
glycosilation), which is typical of the ER, is not only orchestrated to attach big 
hydrophilic groups to the polypeptide but also generates recognition sites for 
folding chaperones (Helenius and Aebi 2004). Folding chaperones begin cycles 
of binding and release with polypeptides protruding from the translocon pore. 
These interactions hide non-folded peptide domains while the protein is folding 
to restrict the freedom of the peptide and drive it to adopt specific kinetically 
and energetically favorable conformations.  
 
The ER contains high concentrations of several folding chaperones. The main 
chaperone set operating in the ER is the glucose-regulated protein (GRP) 
HSP70-like GRP78/Bip and its regulatory proteins. These include the HSP40-
like J-domain containing ERdj1-5 (Shen et al. 2002; Dudek et al. 2005; Shen 
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and Hendershot 2005) and the nucleotide exchange factors BAP and GRP170 
(Chung et al. 2002; Weitzmann et al. 2006). HSP90-like chaperones (GRP94) 
also contribute in ER folding. A typical aspect of the ER involves 
glycosylation-assisted folding which is mediated by resident lectins as calnexin 
and calreticulin (Helenius and Aebi 2004).  
 
PPI and PDI 
Enzymes that modify the topology of the synthesized protein belong to the 
basic set of chaperones. Peptidyl prolyl isomerases (Calebiro et al.) turn the 
peptide, which is blocked by the interaction of proline side chains with the 
peptide backbone (Barik 2006). Another typical aspect of the ER is its 
oxidative environment that permits disulphide bonds formation. Protein 
disulfide isomerase (PDI) enzymes containing paired cysteines (CXXC) 
motifs, use this paired residues to reduce and oxidize incorrect S-S bonds in 
client proteins. The oxidative potential of the ER is generated by ER oxidase 1 
(Ero1) and Erv2 to balance the oxidized and reduced PDIs (Sevier and Kaiser 
2002; Sevier and Kaiser 2006; Sevier et al. 2007). 
 
In order to advance in the folding reaction, peptide domains (in particular 
hydrophobic domains that will be packed whithin the protein core) need to be 
stabilized in a protective environment. This environment is generated through 
transient chaperone binding to the client polypeptides. 
  
GRP78/Bip  
The ER chaperone GRP78/Bip interacts widely and with low affinity with 
hydrophobic peptide domains (Blond-Elguindi et al. 1993). J-domain 
containing ERdj1-5 proteins induce ATP hydrolysis on GRP78/Bip and the 
ADP-bound chaperone presents enhanced client-peptide binding affinity (Shen 
et al. 2002; Dudek et al. 2005; Shen and Hendershot 2005). Nucleotide 
exchange and ATP binding mediated by proteins such as BAP, promote 
peptide-client release to allow for the progression of folding (Chung et al. 
2002).  
 
Lectin-chaperones 
Another mechanism is responsible of the on and off binding of lectin 
chaperones with client polypeptides by enzymatic modulation of the peptide-
attached N-glycan (Helenius and Aebi 2004). Calnexin and its luminal soluble 
homolog Calreticulin are lectin-chaperones that interact with N-glycosilated 
polypeptides by binding to the monoglycosylated glycan Glc(1)Man(7-
9)GlcNAc(2) present on glycoprotein-clients (Hebert et al. 1995; Cannon et al. 
1996; Hebert et al. 1996). Calnexin displays a cytosolic tail, a transmembrane 
domain and an ER lumenal domain containing a beta sandwich domain 
characteristic of lectins (Schrag et al. 2001; Williams 2006). Calreticulin is a 
soluble homolog of calnexin that resides in the lumen of the ER and contains a 
similar glycan-binding domain.  
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Glucosydase I and II 
The specific interaction of calnexin and calreticulin with monoglycosilated 
glycans regulates their binding to client proteins. To generate this glycan 
binding site, ER enzymes glucosydase I and II sequentially remove the two 
glucose residues from Glc(3)Man(9)GlcNAc(2) on the nascent polypeptides 
(Helenius and Aebi 2004; Deprez et al. 2005). Glucosydase II can further 
remove the last glucose residue and abolish the binding site for these lectin 
chaperones. The ER enzyme glucosyl transferase re-glucosylates Man(7-
9)GlcNAc(2) to renovate the binding site for calnexin and calreticulin and 
allow for cyclic client-chaperone interactions that guide folding (Hebert et al. 
1995; Cannon et al. 1996; Hebert et al. 1996; Helenius and Aebi 2004).  
 
Several studies suggested that calnexin, calreticulin, GRP78/Bip and GRP94 
assemble in high molecular weight complexes with a nascent polypeptide (Tatu 
and Helenius 1997). Therefore, chaperones in the ER form a network that 
propagate folding. Calnexin and calreticulin directly bind a glycoprotein-
oxidoreductase ERp57 to permit the formation of disulphide bonds in the 
monoglucosylated unfolded proteins (Leach et al. 2002; Williams 2006). The 
cytosolic tail of calnexin, binding the ribosome complex, links the two sides of 
the ER membrane to couple protein synthesis and folding (Chevet et al. 1999; 
Delom and Chevet 2006; Aridor 2007).  
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1.5 Decision making in the ER 
 
The ER contains high concentrations of unfolded peptides. Molecular QC is 
required to distinguish between proteins that acquire the correct fold and those 
that cannot achieve the correct structure required to progress through the 
secretory pathway. Non-folding proteins are removed by degradation to 
prevent accumulation and possible toxic aggregation. The crucial role of the 
ER in controlling the QC leads to the development of several ER-folding 
related diseases. 
One molecular QC mechanism utilizes N-glycan to monitor the progression of 
folding. Removal and re-addition of the terminal glucose on 
Glc(1)Man(9)GlcNAc(2) by glucosidase II and glucosyltransferase (GT1) 
respectively, activate a loop of interactions between folded proteins and 
calnexin and calreticulin (Hebert et al. 1995; Schrag et al. 2001; Helenius and 
Aebi 2004; Williams 2006). Importantly, GT1 recognizes exposed 
hydrophobic domains in folding intermediates. Thus, GT1 selectively supports 
a productive folding pathway. The preferential re-glucosylation of partially 
folded intermediates directs the progression of the folding reaction (Caramelo 
et al. 2003; Caramelo et al. 2004). Furthermore, the cyclic bond between 
calnexin, calreticulin and client proteins are eventually broken by the removal 
of mannose residues from three branches of Man(9)GlcNAc(2) by ER 
mannosidases I and II, leading to the formation of Man(7-8)GlcNAc(2). These 
N-glycan, which are formed due to prolonged retention in the ER is 
inefficiently recognized by glucosidase II and GT1. Therefore the cycles of 
binding and release between client polypeptides and lectins are inhibited, 
interrupting protein-folding (Parodi 2000; Cabral et al. 2001; Totani et al. 
2006). One of the mechanisms to recognize N-glycosylated clients for 
degradation involves the recognition of mannose trimmed N-glycans 
[Man(9)GlcNAc(2)] by ER lectins or enzymes of the ER degradation-
enhancing alpha-mannosidase-like protein (EDEM) family (EDEM1-3). 
EDEM proteins were identified as a homologous of ER mannosidases that are 
up-regulated during ER stress and facilitate ER degradation (Oda et al. 2003; 
Olivari et al. 2005; Hirao et al. 2006). Moreover several evidences suggest that 
EDEM proteins not only bind but may also generate mannose trimmed N-
glycans (Hirao et al. 2006; Olivari et al. 2006). The overall effect of EDEM 
recognition is to target client proteins for ER degradation (Olivari and Molinari 
2007). EDEM proteins were shown to interact directly with components of the 
ER degradation machinery thus linking QC with ER degradation (Oda et al. 
2006; Kabani et al. 2003).  
Similarly, defects in protein folding located within cytoplasmic domains of 
membrane proteins are monitored through the interaction between cytosolic 
folding chaperones and client proteins. For example, degradation of CFTR is 
controlled by interactions with the cytosolic Hsc70 and HSP90, but modulation 
of these interactions can promote either folding or degradation (Meacham et al. 
2001; Wang et al. 2006; Younger et al. 2006).  
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1.6 Quality Control: the folding out of the ER 
 
QC pathways exists because proteins fold in an unfavorable cellular 
environment due to molecular crowding and relatively high temperatures (Ellis 
2007). These two conditions favor aggregation inhibiting folding. Molecular 
chaperones favour folding preventing aggregation. This is achieved via weak 
interactions between the molecular chaperones and the exposed hydrofobic 
groups of unfolded or misfolded proteins. Under normal cellular conditions the 
expression level of molecular chaperones is fitted to the overall level of protein 
synthesis. Under stressfull conditions, mature proteins unfold and surpass the 
capacity of chaperone machinery to prevent aggregation. This stress condition 
induces feedback response which results in increased expression level of 
molecular chaperones, due to the de-repression of the heat shock transcription 
factor Hsf1. Importantly, Hsp90 plays a role in Hsf1 repression via direct 
interaction. Under stress conditions, or inhibition with small molecules, Hsp90 
dissociates from Hsf1 resulting in its activation (Zou et al. 1998). This 
stressfull events is associated with the accumulation of aggregates containing 
damaged proteins. It seems clear, however, that aggregation represents the last 
attempts to avoid the degradation of misfolded proteins by the 
ubiquitin/proteasome system. It happens only when this system becomes 
insufficient that aggregation ensues.  
The role of Hsp90 in the QC system was not appreciated until the 
benzoquinoid ansamycin, geldanamycin, was shown to be a specific inhibitor 
of the chaperone (Whitesell et al. 1994). Several studies revealed that client 
protein kinase and trascription factors were rapidly degraded via the 
ubiquitin/proteasome pathway. This evidence led to the development of more 
13 small molecules currently in clinical trials as chemotherapeutics (Trepel et 
al. 2010). 
It is well established that Hsp90 sits at the distal end of the pathway of 
chaperone interactions for newly made trascription factors and protein kinases 
(Taipale et al. 2010). For example, newly made nuclear receptors such as the 
glucocorticoid receptor and the progesterone receptor interact with Hsp70 and 
Hsp40 chaperones before to recruitment to Hsp90 by the participation of Hop, 
the Hsp organizing protein (Pratt and Toft 2003). The mechanism by which 
client protein folding is regulated by Hsp90’s reaction cycle is still unclear. 
What is clear, however, is that many small molecule inhibitors act certainly by 
competitive inhibition mechanism of Hsp90’s ATPase, which occurs in the N-
domain of the chaperone (Prodromou et al. 1997). The inhibition of Hsp90 
results in rapid degradation via ubiquitin/proteasome pathway for many, but 
not all, clients. It seems likely that N-terminal inhibitors promote degradation 
as a consequence of blocking the folding pathway. N-terminal Hsp90 inhibitors 
appear to promote the reorganization of chaperone complexes. For protein 
kinases, there is an increase in Hsp70 binding to the client with a reduction in 
Hsp90 binding (An et al. 2000). These findings correlate with the role of 
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Hsp70 in degradation processes (Kettern et al. 2010).  This is coherent with 
Hsp70’s ability to coordinate with different ubiquitin ligases, including CHIP 
and Ubr1 (Connell et al. 2001; Meacham et al. 2001; Nillegoda et al. 2010). 
Several molecular chaperones and co-chaperones function in both folding and 
degradation processes. Sse1, the Hsp110 chaperone that acts as a nucleotide 
exchange factor for Hsp70 (Shaner and Morano 2007) is required for the 
degradation of client protein kinases upon treatment with geldanamycin in 
vivo. (Mandal et al. 2010). This action requires direct interaction between Sse1 
and Hsp70 and occurs before the protein is ubiquitylated. By contrast, loss of 
function of the Hsp40 co-chaperones Ydj1 leads to a rapid degradation of 
protein kinases, suggesting that is has a protective role for newly synthesized 
Hsp90 clients (Mandal et al. 2008). Ydj1 also functions as an Hsp70 co-
chaperone, and stimulates Hsp70’s ATPase, stabilizing Hsp70-client 
complexes (Cheetham and Caplan 1998). The distinct roles of Ydj1 and Sse1 
as Hsp70 co-chaperones suggests a model in which the stable association of a 
client with Hsp70 is protective against degradation for client proteins. By 
contrast, complex dissociation is required for degradation when folding 
pathways are inhibited with geldanamycin. 
There are several examples showing that Hsp90 is required for degradation of 
membrane proteins in the ER. These include cytochrome p450 2E1, mutant 
CFTRΔF508 and Apolipoprotein B. In each of these cases, geldanamycin was 
found to inhibit degradation in cell free system when the protein was added to 
cytosolic extracts in the form of microsomes (Fuller and Cuthbert 2000; 
Goasduff and Cederbaum 2000; Gusarova et al. 2001). The example of  
CFTRΔF508  is intriguing since this mutant form is stabilized upon Hsp90 
inhibition in vitro, while the wild type counterpart is destabilized in cells 
treated with geldanamycin (Loo et al. 1998). This may suggest that the relative 
contribution of Hsp90 to the QC process strictly depends on the folding 
potential of the client. 
These findings suggest that the chaperone machinery can be reprogrammed 
depending on the folding status of the client, and that clients whose folding 
potential is low eventually interact with a chaperone proteins responsible of 
degradation (Holmes et al. 2008; Theodoraki and Caplan 2012). 
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1.7 The Ubiquitin Proteasome System 
 
When a protein fails to reach energetically stable conformation it is adressed to 
degradation. Importantly, degradation of proteins in the ER (ERAD; ER 
associated degradation) is a specific and finely regulated process. The cytosolic 
proteasome complex mediates ERAD. Unstable or misfolded proteins are 
retro-traslocated from the ER to the cytosol for ubiquitinylation and 
degradation. Therefore, the folding environment of the ER is physically 
distinct from the main site of protein degradation (Jensen et al. 1995; Ward et 
al. 1995; McCracken and Brodsky 1996; Romisch 2005). 
The specificity of protein degradation in the ER is conferred by 
ubiquitinylation. E3 ubiquitin ligases provide the recognition of targeted 
proteins or chaperones associated with target proteins, selecting ERAD 
substrates (Ciechanover 1994) for the ER-localized E2 enzymes action that  
transfers ubiquitin to the selected proteins, tagging those for proteasome-
mediated degradation (Xu et al. 2006; Romisch 2005). For example, unstable 
folding intermediates at the N-terminal domain of CFTR is detected at the 
onset of synthesis and are recognized by a ubiquitin ligase complex assembled 
at the cytosolic face of the ER to mediated ER-retention, ubiquitinylation and 
degradation.  
Proteins selected for degradation (including lumenal proteins) are dislocated 
from the ER to the cytosol (McCracken and Brodsky 1996; Wiertz et al. 1996; 
Romisch 2005) probably via Sec61 traslocon complex, which mediates peptide 
insertion into the ER, to mediate reverse traslocation to the cytosol. However, 
direct evidence for the role of the traslocon complex in ERAD is still lacking 
(Aridor 2007). 
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1.8 Frizzled receptors 
  
Frizzled proteins (Fzs), are cell surface receptors involved in a variety 
biological processes during development as well as in adult life. Human as well 
as mouse genome has 10 different genes that codify for 10 different receptors. 
The primary structure of all ten mammalian Fzs displays many landmarks 
observed in virtually all G protein-coupled receptors, including an ectosolic N-
terminus that is N-glycosylated, seven hydrophobic transmembrane segments 
predicted to form α-helices, three intracellular and extracellular loops, and a 
cytosolic tail that harbor potential sites of protein phosphorylation [Fig. 2 
(Schulte et al. 2007)].  
Putative glycosylation sites on the extracellular loops of Fzs could be involved 
in ligand binding and have been shown to be important for receptor maturation 
in ER, which is regulated in a specific manner by the protein Shisa (Yamamoto 
et al. 2005). Sequence and mutational analyses revealed the presence of two 
PDZ (PSD-95/dics large/ZO-1 homologous) binding domains in the cytosolic 
tail, providing a protein-interacting interface for the receptor. The 
juxtamembrane KTxxxW motif is conserved among all 10 Fz receptors, while 
the second PDZ-binding motif, at the C-terminus of the receptors, is present 
only in Fz-1, -2, -4, -7 (Luyten et al. 2008)(Fig.10). The extracellular domain 
of Fzs can bind several secreted molecules and some are considered to be 
cognate ligands. The primary endogenous agonists are the WNT proteins, of 
which there are 19 mammalian forms. These proteins are able to trigger most 
of the Fz-mediated signaling pathways.   
However, recent findings suggest that at least three other protein families can 
directly bind Fzs and activate downstream signaling: soluble Frizzled-related 
proteins (soluble FRPs), R-spondin and Norrin. R-spondin and Norrin were 
shown to interact with the CRD (cystein reach domain), while sFRPs were 
initially seen as WNT scavengers that prevented WNT binding to Fzs.  
However, recent studies support the idea of direct binding of sFRPs to Fz-
CRDs, probably by CRD dimerization followed by receptor activation, as in 
the case of sFRP1-mediated activation of Fz2 (Rodriguez et al. 2005).  
The main signaling pathways [Fig. 3 (Wawrzak et al. 2009)] activated by all 10 
Frizzled receptors are:  
1. Fz/β-catenin pathway: agonist stimulation results in the activation of the 
phosphoprotein Dishevelled (DVL), leading to inhibition of a constitutively 
active glycogen-synthase kinase 3 within a destructive complex consisting of 
APC (adenomatous polyposis coli) and axin, which regulates the 
phosphorylation and destruction of b-catenin. The b-catenin thus spared is 
translocated to the nucleus, where it cooperates with TCF/LEF transcription 
factors to modify gene transcription (Gordon and Nusse 2006).  
2. Fz/Ca2+ pathway: The agonists induce elevation of intracellular calcium 
levels in a G-protein-dependent manner either directly, through activation of 
phospholipases (Slusarski et al. 1997), or indirectly, via a decrease in 
intracellular cyclic GMP (Ma and Wang 2006), resulting in activation of 
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calcium-dependent kinases, such as calcium-dependent protein kinase (PKC) 
and Ca2+/calmodulin-dependent protein kinase.  
3. Fz/PCP (planar cell polarity) pathway: The information is believed to be 
transduced via DVL to the small GTPases RHO and RAC and their effectors, 
which are mainly ROCK (RHO kinase) and the c-jun- N-terminal kinase-c-jun-
AP1 pathway (Seifert and Mlodzik 2007). 
  
Mutagenesis has revealed that several residues in the intracellular loops and in 
the C-terminal domain of Fzs are crucial for signaling. Specifically, the 
mutation of the highly conserved internal KTxxxW motif in the C terminus, or 
single amino acid exchanges in the first (R340A) or the third (L524A) 
intracellular loops of human Fz5, completely abolished Fz signaling.  
Importantly, identical mutations completely ablated the binding of DVL (DSH 
in Xenopus and Drosophila) and its membrane recruitment by Fzs (Cong et al. 
2004).  
Figure 2: Schematic view of the assembly in the membrane of 
Fz receptors. The model indicates extra and intracellular interacting 
proteins, putative glycosylation and phosphorylation sites. The N-
terminal CRD is the primary binding site for ligands. The red stretch 
in the C terminus indicates the internal PDZ-interacting motif 
(KTxxxW), which is absolutely conserved in the different Fz 
isoforms and necessary for DVL binding and signaling. The blue 
stretch at the C-terminus indicates the presence of a classical, less 
well-conserved PDZ-ligand sequence present in a subset of Fz. 
Figure 3: Schematic representation of the Wnt signaling pathways. a) 
The canonical, Wnt/b-catenin pathway. Binding of the Wnt ligand to the 
Fz and to the co-receptor of the LRP family leads to phosphorylation of 
Dishevelled (Dsh/Dvl), and to titration of Axin away from the !-catenin 
degradation complex, composed of APC, GSK-3 and Axin itself. As a 
consequence, the degradation complex cannot assemble, !-catenin is 
stabilized and translocates to the nucleus where, together with transcription 
factors of the Tcf/Lef family, it activates Wnt target genes, such as c-myc 
and cyclin D1. b) The non-canonical, !-catenin independent pathways: the 
PCP and the Ca2+ pathway. A main branch of the PCP downstream of 
Dsh/Dvl involves the small GTPases of the Rho family, Rac and c-Jun N-
terminal kinase (JNK). Dsh/Dvl can also stimulate calcium flux and 
protein kinase C (PKC) and calmodulin-dependent protein kinase II 
(CAMKII). The non-canonical Wnt signaling controls cell movement and 
tissue polarity. Heparan sulfate proteoglycans (HSPG) are known to bind 
and to concentrate Wnt at the cell surface and to influence Wnt signaling. 
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1.9 Familial exudative vitreoretinophaty (FEVR)  
  
Familial exudative vitreoretinopathy (FEVR) is characterized by failure of 
peripheral retinal vascularization. The visual problems associate with FEVR 
result from secondary complications caused by retinal ischemia. The retinal 
avascularity is probably present from birth and generates sequelae that stabilize 
in early adult life or progress in later life. Expressivity may be asymmetric and 
is highly variable, ranging from mild or asymptomatic to severe (e.g., 
registered as blind) within the same family. The diagnosis of FEVR is based on 
bilateral peripheral retinal avascularity diagnosed by indirect ophthalmoscopy 
and fundus fluorescein angiography. Four genes are known to be associated 
with FEVR: FZD4, encoding for Fz4 receptor, LRP5, encoding for low-density 
lipoprotein receptor-related protein 5 (Robitaille et al. 2002), NDP, encoding 
for the secreted protein Norrin, that is one of the principal agonist Fz4 ligands 
(Sims 1993) and TSPAN12, a member of the tetraspanin superfamily (Poulter 
et al. 2010). In all cases, mutations affect the activation of the pathway 
promoted by Fz4 receptor.  
It as been shown that Fz4 signaling regulates endothelial cells (EC)/mural cells 
(MC) interactions and is essential for vascular integrity in the retina and 
cerebellum (Ye et al. 2009). Furthermore, Fz4 is present throughout the 
developing and adult vasculature, and its inactivation results in severe vascular 
disorganization. It has been shown, cultured Fz4-/- retinal embrional cells 
(Recsei et al.) are unable to form capillary-like structures but can integrate into 
these structures when they are formed by WT RECs. Moreover, 
Norrin/Fz4/Lrp signaling controls a transcriptional program in endothelial cells 
that is, at least partially, mediated by Sox17. These results establish 
Norrin/Fz4/Lrp signaling as a central regulator of REC development, and they 
indicate that the hypovascularization responsible for FEVR, Norrie disease or 
osteoporosis-pseudoglioma syndrome arises from the impairment of a specific 
transcriptional program. They also suggest that Fz4/Lrp signaling could play a 
role in vascular growth, remodeling, and maintenance in a variety of normal 
and pathologic contexts beyond the retina (Ye et al. 2009). 
Among all described mutations associated to the FEVR, only the Fz4 
L501fsX533 is associated with the autosomal dominant form (Kondo et al. 
2003). This mutation consists in a deletion of a di-nucleotide (ct) in 1501-1502 
position in exon2 of the FZD4 gene that results in a frameshift mutation that 
starts at the leucine in position 501 and finishes in position 533 where it 
introduces an early stop codon. In transfected cells, the effect of this mutation 
is the total absence of the mutant receptor on the plasma membrane (Robitaille 
et al. 2002). Most importantly, the mutant receptor acts as a dominant negative 
by trapping the wild-type counterpart in the ER by oligomerization (Kaykas et 
al. 2004). 
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2. Aim of the study 
 
The correct activity of a protein relates on its tridimensional fold. Functionality 
is achieved when each of the domains of a protein acquire the right structural 
conformation. Similarly, disordered regions need to remain as such. Genetic 
mutations alter the primary sequence of a protein interfering with the 
acquisition of a specific conformation or dictating a new fold. The intracellular 
destiny of the protein and its activity depends on the effect of these mutations. 
The protein may remain active otherwise a less active or, more drastically, a 
misfolded unfunctional protein may be generated. Many examples of the effect 
of genetic mutations on the structured regions of proteins are described  (Illing 
et al. 2002; Kim et al. 2009; Hirota et al. 2010). However, less is known on the 
result of amino acid substitutions in their disordered parts.  
Frizzled4 (Fz4), belongs to the family of Frizzled cell surface receptors 
involved in a variety of biological processes during development as well as in 
adult life (Schulte and Bryja 2007). The frameshift mutation L501fsX533 of 
Fz4 receptor is associated with a rare form of Familial exudative 
vitreorethinopaty (FEVR) (Robitaille et al. 2002). The mutation generates a 
different and shorter C-terminal cytosolic tail. The resulting mutant receptor 
fails to reach the Plasma Membrane (PM) of the cells and accumulates in the 
ER (Robitaille et al. 2002; Kaykas et al. 2004). 
This misfolded mutant would trap wild type chains by improper 
heteroligomerization abolishing Fz4 signaling from the cell surface during 
retinal development by a dominant negative mechanism (Kaykas et al. 2004). 
This loss of function results in aberrant vascularization of the retina during 
development with severe consequences for the patients (Xu et al. 2004; Wang 
et al. 2012). 
The aim of the present work was to elucidate the causes of misfolding and ER 
retention of Fz4 receptor induced by disease mutation L501fsX533, i.e. a first 
step to envisage therapeutic perspectives for the cure for adFEVR.  
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3. Materials and methods 
  
  
All culture reagents were obtained from Sigma-Aldrich (Milan, Italy). Solid 
chemicals and liquid reagents were obtained from E. Merck (Darmstadt, 
Germany), Farmitalia Carlo Erba (Milan, Italy), Serva Feinbiochemica 
(Heidelberg, Germany), Delchimica (Naples, Italy) and BDH (Poole, United 
Kingdom). The radiochemicals were obtained from Perkin Elmer (Bruxelles, 
Belgium). Protein A-Sepharose CL-4B and the ECL reagents were from 
Amersham Biosciences (Milan, Italy). Protease Inhibitor Cocktail was obtained 
from Roche (Milan, Italy). ANAPOE-C10E6 was obtained from Affymetrix 
(Santa Clara, California). 
 
Antibodies  
The following antibodies were used: mouse monoclonals anti-HA (Santa Cruz 
Biotechnology Inc.); rabbit polyclonal anti-HA (Sigma Aldrich); rabbit 
polyclonals anti-Calnexin (StressGene); Texas-Red-conjugated goat anti-
mouse or rabbit IgG, FITC-conjugated goat anti-mouse or rabbit IgG (Jackson 
Immunoresearch Laboratories, West Grove, PA, USA).  
 
Peptides 
Sinthetic peptides corresponding to the sequence of: 
wt (CSAKTLHTWQKCSNRLVNSGKVKREKRGNGWVKPGKGSETVV),  
FEVR (CSAKTSHVAEVFQQIGEFWKGKEREERKWLGEAWKRQ),  
FEVR-6Ala (CSAKTSHVAEVFQQIGEFWKGKEAAAAAALGEAWKRQ)  
were purchase at GL Biochem (Shanghai). 
The liophilized were risospended in water at concentration of around 5mg/mL 
each, to be then further diluited in the appropiate buffer. Concentration were 
determined with NANODROP 2000 Spectrophotometer, Thermo Scientific, 
using extintion coefficient (εwt=11125, εFEVR = 16500, ε6Ala=11000).  
 
Structure prediction 
Structure prediction of Fz4 wt, FEVR and all mutant tails were performed at 
server Protein Model Portal (PMP) (Arnold et al. 2009) and I-Tasser-Protein 
structure e functional prediction (Zhang 2008). Cartoon representations, r.m.s. 
deviation, dihiedral and planar angle were generated in Pymol Molecular 
Graphics System, Version 1.5.0.4 Schrodinger, LLC. 
 
 
Disorder prediction 
Disorder predictions were generated in DisEMBL Intrinsic Protein Disorder 
Prediction 1.5 (Linding et al. 2003). 
Predictions of Transmembrane regions were generated in HMMTOP Version 
2.0 (Tusnady and Simon 1998). 
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Circular Dichroism 
CD spectra were recorded in a Jasco J-710 CD Spectrophotometer. 
Peptides were diluited  to the final concentration of 10-4M in NaCl 150mM and 
were indicated ANAPOE 2% final solution was included. 
Data were recorded in wavelenght range of 200nm to 320nm with a data pitch 
of 1nm, in a continuous scanning mode at speed of 50nm/min. 4 seconds of 
response in standard sensitivity e 20 accumulation were used to generate the 
averaged spectra. 
 
Trp fluorescence quenching and polarization  
Peptides, 10 µM (in Hepes 50mM pH 8, 150mM NaCl) were equilibrated with 
dilutions of the 
micellar agent ANAPOE C10E6 one hour before fluorescence measurement. 
Equilibrium fluorescence andPolarization measurement were monitored using 
a PheraStar fluorescence plate reader in 96 well plates.Peptides were excited at 
280nm, and emission intensity was monitored at 340nm with an emission slit 
of 8 nm. Triplicates of the data were normalized and fitting to a sigmoidal 
dose-response curve was done in GraphPad. 
 
Cell culture, transfection and immunofluorescence  
Human HEK293T and Huh-7 cells were routinely grown at 37ºC in Dulbecco’s 
Modified Essential Medium (DMEM), containing 10% fetal bovine serum 
(FBS) and transfected by using FuGene 6.0 according to the manifacturer 
instruction (Standley et al.).  
Indirect immunofluorescence was performed as previously described 
(Stornaiuolo et al. 2003). Single confocal images were aquired  at 63x and 
100x magnification on a LSM510 Zeiss Confocal Microscope (Carl Zeiss Jena, 
Germany). 
To separately stain Fz4 proteins on either cell surface (extra) or intracellular 
membranes (Staub et al.), indirect immunofluorescence was performed as 
previously described (Mottola et al. 2002; D'Agostino et al. 2011).   
 
 
Pulse-Chase & EndoH assay  
HEK293T cells, transiently transfected with HA-Fz4 and HA-Fz4-FEVR for 
48hrs, were starved with a modified DMEM without CYS/MET aminoacids, 
containing 1% FBS. After 30 minutes the cells were incubated (PULSE) for 20 
minutes with the same modified DMEM containing S35-CYS/MET  
(100∝ci/ml). After washing with PBS1X the cells were incubated (CHASE) 
for 2 and 4hrs with the unmodified DMEM 10% FBS containing 
cycloheximide (inhibitor of protein biosynthesis). After washing with PBS1X, 
HA-Fz4 and HA-Fz4-FEVR proteins were immonoprecipitated by using a 
mouse monoclonal anti-HA antibody for 16hrs at 4°C followed by Protein A-
Sepharose beads (Pharmacia). After washing with the buffer used for the lysis, 
the immunoprecipitated proteins were treated with EndoH enzyme, according 
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to the manufacturer's instructions, and analyzed by SDS-PAGE.  
 
Temperature shift assay  
Huh-7 cells were cultured on coverslips and transfected with different VSVG 
constructs. After 2hrs at 37°C, cells were incubated at the non permessive 
temperature of 40°C for 16hrs. After this period, the first coverslips were fixed 
in formaldehyde 3,7% while the others were cultured at 32°C for 20 minutes 
before the fixation.  
 
Velocity gradient  
Cell lisates, diluted in glycerol at the final concentration of 6%, were loaded on 
the top of discontinuous 20 to the 40% glycerol gradients (5ml final volume). 
After ultracentrifugation in the SW40.1 rotor at 45000 rpm of 16hrs, 14 
fractions were collected from the bottom of the gradient. All fraction were 
precipitated in 15% TCA for 2hrs at 4°C. After 30 minutes of centrifugation, 
the pellets were washed two times with ice cold acetone, solubilized in 
Laemmli Buffer and analyzed by SDS-PAGE.  
 
cDNA cloning and plasmid construction 
The construct pCDNA5-HA-Fz4 was kindly provided by M. MacDonald and 
M.R. Hayden. The mutant L501fsX533 (Fz4-FEVR), was obtained by site 
direct mutagenesis using the following oligos:  
Fz4-FEVR  
Fw: 5’-TGGTCTGCCAAAACTTCACACGTGGCAGAAG-3’  
Rv: 5’-AGTTTTGGCAGACCAAATCCACATG-3’  
 
To obtain all the mutants in Alanin of Fz4-FEVR the construct pCDNA5-HA-
Fz4-FEVR was used as a  
template and the site direct mutagenesis assay was performed according to the 
manufacturer instruction (Standley et al.). 
-HA-Fz4-FEVR1-525  
Fw: 5’-GAGAGGAAATGGTTGTGAGAAGCCTGGAAAAGGC-3’ 
Rev: 5’-CAACCATTTCCTCTCTTCTC-3’ 
-HA-Fz4-FEVR1-515 
 Fw: 5’-GGTGAATTCTGGAAATGAAAAGAGAGAGAAGAG-3’ 
Rev: 5’-TTTCCAGAATTCACCAATCTGTTGG-3’ 
-HA-Fz4-FEVR1-509 
Fw: 5’-GAAGTGTTCCAACAGTGAGGTGAATTCTGGAAAGG-3’ 
Rev: 5’-CTGTTGGAACACTTCTGCCACG-3’ 
-HA-Fz4-FEVR1-498 
Fw: 5’-GCATGTGGATTTGGTCTTGAAAAACTTCACACGTGG-3’ 
Rev: 5’-AGACCAAATCCACATGCCTGAAG-3’ 
-HA-Fz4-FEVR  W514A 
Fw: 5’-CAGATTGGTGAATTCGCGAAAGGTAAAGAGAGAGAAG-3’ 
Rev: 5’-GAATTCACCAATCTGTTGGAAC-3’ 
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-HA-Fz4-FEVR K517A-E518A  
Fw: 5’-GAATTCTGGAAAGGTGCAGCGAAAGAGAGAGAAGAG-3’ 
Rev: 5’-CCAGAATTCACCAATCTGTTG-3’ 
-HA-Fz4-FEVR R519A 
Fw: 5’-TGGAAAGGTAAAGAGGCAGAAGAGAGGAAATGG-3’ 
Rev: 5’-CTCTTTACCTTTCCAGAATTC-3’ 
-HA-Fz4-FEVR R519AE520A 
Fw: 5’-TGGAAAGGTAAAGAGGCAGCAGAGAGGAAATGGTTG-3’ 
Rev: 5’-CTCTTTACCTTTCCAGAATTC-3’ 
-HA-Fz4-FEVR E520AE521A 
Fw: 5’-GAAAGGTAAAGAGAGAGCAGCGAGGAAATGGTTGGGTG-3’ 
Rev: 5’-TCTCTCTTTACCTTTCCAGA-3’ 
-HA-Fz4-FEVR R522AK523A 
Fw: 5’-AAAGAGAGAGAAGAGGCGGCATGGTTGGGTGAAGCC-3’ 
Rev: 5’-CTCTTCTCTCTCTTTACCTTTC-3’ 
-HA-Fz4-FEVR K523A 
Fw: 5’-GAGAGAGAAGAGAGGGCATGGTTGGGTGAAGCC-3’ 
Rev: 5’-GTAAAGAGAGAGAAGAGAGG-3’ 
-HA-Fz4-FEVR E521AR522A 
Fw: 5’-GGTAAAGAGAGAGAAGCGGCGAAATGGTTGGGTGAA-3’ 
Rev: 5’-TTCTCTCTCTTTACCTTTCC-3’ 
-HA-Fz4-FEVR K523AW524A 
Fw: 5’-GAGAGAGAAGAGAGGGCAGCGTTGGGTGAAGCCTGG-3’ 
Rev: 5’-CCTCTCTTCTCTCTCTTTAC-3’ 
-HA-Fz4-FEVR W524A 
Fw: 5’-AGAGAAGAGAGGAAAGCGTGGTTGGGTGAAGCC-3’ 
Rev: 5’-GAATTCACCAATCTGTTGGAAC-3’ 
-HA-Fz4-FEVR G526AE527A 
Fw: 5’-GAGAGGAAATGGTTGGCTGCAGCCTGGAAAAGGCAG-3’ 
Rev: 5’-CAACCATTTCCTCTCTTCTC-3’ 
A procedure in three steps was used to generate HA-Fz4-FEVR-6Ala cDNA, 
using for each step the following couple of primers: 
1° step: see Materials and Methods of HA-Fz4-FEVR R519AE520A. 
2° step: -HA-Fz4-FEVR E521AR522A (4Ala) 
Fw: 5’-CTGGAAAGGTAAAGAGGCAGCAGCGGCGAAATGGTT 
GGGTGAAG-3’ 
Rev: 5’-CTCTTTACCTTTCCAGAATTC-3’ 
3° step: -HA-Fz4-FEVR K523AW524A (6Ala) 
Fw: 5’-GAGGCAGCAGCGGCGGCAGCGTTGGGTGAAGCCTGG-3’ 
Rev: 5’-CGCCGCTGCTGCTCTCTTTAC-3’ 
The template for each step was the product of the previous one. 
 
To obtain the constructs 3xFLAG-VSVGts045-Fz4wt tail and 3xFLAG-
VSVGts045-Fz4-FEVR tail, the regions encoding for the ectodomain and 
transmembrane domain (LTM) of VSVG and the tailes of Fz4wt or Fz4-FEVR 
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were isolated from the cDNAs of the respective proteins and subcloned in the  
3xFLAG-CMV-7.1 expression vector by using the following oligos:  
  
VSVG (LTM)  
Fw (HindIII): 5’-AAGCTTAAGTTCACCATAGTTTTTCC-3’  
Rv (BglII): 5’-AGATCTGAGAACCAAGAATAGTCC-3’  
  
Fz4-wt tail  
Fw (BglII): 5’-AGATCTATGGACATCGCCATCCACCACCC-3’  
Rv (XbaI): 5’-TCTAGACTATTTCTTGGGGGCTGCGG-3’  
  
Fz4-FEVR tail  
Fw (BglII): 5’-AGATCTATGGACATCGCCATCCACCACCC-3’  
Rv (XbaI): 5’-TCTAGACTATTTCTTGGGGGCTGCGG-3’ 
 
Constructs were confirmed by sequencing. 
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4. Results 
 
4.1 Intracellular destiny of Fz4-FEVR protein 
 
HA-tagged Fz4 wt transiently overexpressed in Huh-7 (Fig. 4a) (as well as in 
HEK 293 and COS-7, data not shown) cells, localizes on the PM as shown by 
immunofluorescence staining performed on unpermeabilized cells. In contrast, 
HA-tagged Fz4-FEVR transiently expressed in the same cell lines (Fig. 4b) 
does not appear on the PM suggesting an intracellular localization of the 
mutant protein. The immunofluorescence performed after permeabilization 
reveals HA-Fz4 mainly in a pericentriolar region of the cells corresponding to 
the Golgi complex (Fig. 4c), while HA-Fz4-FEVR shows an ER localization 
(Fig. 4d). Double immunofluorescence of HA-Fz4 (Fig. 4e) or HA-Fz4-FEVR 
(Fig. 4f) with the ER marker calnexin confirmed the ER localization of the 
mutant protein. We know that Fz4-FEVR forms covalently linked aggregates 
trapped in the ER (personal communication). Comparison of the mobility on 
SDS-PAGE of non reduced samples confirmed that in Huh-7 (Fig. 4g) and in 
HEK 293 cells (data not shown) Fz4-FEVR fails to correctly fold forming 
covalently S-S linked aggregates. To further prove the ER localization of HA-
Fz4-FEVR, endo-H sensitivity of the protein was tested in a pulse-chase assay. 
HA-Fz4 and HA-Fz4-FEVR were transiently expressed in HEK 293 cells. 
After 20 minutes of pulse in a 35S Cys and Met containing medium, cells were 
chased in unlabelled medium for 2 and 4 hours. Both HA-Fz4 and HA-Fz4-
FEVR were sensitive to Endo H treatment immediately after the pulse (Fig. 
4h). After 2 and 4 hours of chase a Endo H resistant band appeared for Fz4 but 
not for Fz4-FEVR confirming that the wild type protein but not the mutant 
acquired the Golgi specific sugar modification responsible for the resistance.  
The new tail of Fz4-FEVR compromices folding of the receptor and causing its 
retention in the ER. 
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Figure 4: Fz4-FEVR fails to reach the Plasma Membrane and 
aggregates in the Endoplasmatic Reticulum. Surface (-Triton) and 
intracellular (+ Triton) localization of Fz4 (a, c) and Fz4-FEVR (b, d) and 
their colocalization with the ER marker Calnexin (e-f) after transient 
transfection in Huh-7 cells. The inset in f shows in yellow region of 
colocalization; g) SDS-PAGE of Fz4 and Fz4-FEVR run in reducing 
(+DTT) and not-reducing conditions 
(-DTT) (monomeric and aggregates forms are indicated); h) Endo-H 
resistence (Golgi) and sensitivity (ER) of newly synthesised Fz4 and Fz4-
FEVR pulse-chased for the indicated time after transient transfection in 
HEK 293 cells.  
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4.2 Conformation of Fz4-FEVR tail in solution 
 
Search in protein databases finds no similarity between the aminoacidic 
sequence of the Fz4-FEVR  tail (Fig. 5a) and any other sequence. Surprisingly, 
structure prediction softwares (see Matherials and methods for details) 
suggested the Fz4-FEVR tail to be folded (Fig. 5a). The prediction indicates 
the mutated tail to acquire a helix-loop-helix conformation. Two consecutive 
helices (helix 1 Ser501 to Gly516 and helix 2 Lys523 to Lys530), connected by a 
six amino acids long loop (Lys517 to Arg522) define the predicted fold (Fig. 5a). 
The loop is predicted due to structure similarity with helix-loop-helix 
containing proteins like transcription factors and calcium binding proteins 
[PDB: 1R9D (O'Brien et al. 2004), 3FGH (Gangelhoff et al. 2009), 1GT0 
(Remenyi et al. 2003)] (Jiang et al. 2010). Charged side chains are common in 
helix connecting loops and are responsible for the curvature, due to their 
interaction with water molecules or with ions (Sharma et al. 1997). The same 
prediction suggests only a smaller helical region for the wt sequence (Lys499 to 
Lys506) (Fig. 5a). The existence of the helix in the wt was already postulated 
and shown to be responsible for the interaction of Fz4 with the effector protein 
Dishevelled (Wong et al. 2000; Punchihewa et al. 2009). The sequence Cys507 
to Val537 of the wt tail was predicted disordered (Punchihewa et al. 2009). 
Softwares predicting disordered region in proteins support the random 
conformation of the C-terminal part of the wt tail but not of the Fz4-FEVR tail 
(Fig. 5a). 
To confirm the predicted fold, a sinthetic peptide corresponding to the Fz4-
FEVR tail was analyzed by Circular Dichroism (Kelly et al. 2005). The 
spectrum was compared with that of a sinthetic Fz4 wt tail and of a modified 
Fz4-FEVR mutant with 6 Alanine residues (Fz4-FEVR-6Ala) replacing the 
sequence between amino acid R519 and W524. Since Alanine stretches have 
more structural flexibility, the carboxyl terminal part of the Fz4-FEVR-6Ala 
peptide was predicted more disordered. Indeed, the CD spectrum of the Fz4-
FEVR tail peptide (Fig. 5c) shows two negative picks at around 208nm and 
222nm proper of an helical fold with a molar ellipticity ratio 
Θ[222nm]/Θ[208nm] proximum to 1 (Kelly et al. 2005).  The CD spectrum of 
the wt also shows two negative picks at the same wavelenghts. The ratio 
Θ[222nm]/Θ[208nm] now is less than 1 suggesting a less structured peptide as 
expected (Kelly et al. 2005). The decrease of molar ellipticity ratio reflects the 
contribution of random fold (minimum at 198nm and maximum at 210-230nm 
region) to the average spectrum (Kelly et al. 2005). In the Fz4-FEVR tail CD 
spectrum a low intensity positive peak around 280nm is also visible. This 
region of the CD spectrum is influenced by aromatic amino acid side chains 
(Trp, Tyr, Phe) only when these are part of folded domain (Heidebrecht et al. 
2012) suggesting the two C-terminal Trp of the FEVR tail being part of a fold. 
The ratio Θ[222nm]/Θ[208nm] in the FEVR-6Ala CD spectrum is lower 
compared to the others confirming the disorder of the tail (Fig. 5c). Differently 
from the spectrum of the Fz4-FEVR tail, no positive signal was present in the 
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280 nm region despite of the presence of two Trp in Fz4-FEVR-6Ala tail. This 
absence would point to a less structured C-terminal part of the Fz4-FEVR-6Ala 
tail. 
The L501fsX533 frameshift mutation induces structural transition in the Fz4 
cytosolic tail. The sequence of Fz4-FEVR tail, but not the one of wt, acquires a 
stable alpha-helix conformation in solution. The region R519-W524 confers 
stability to the fold. 
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Figure 5: Fz4 wt tail and FEVR tail have a different fold. a) 
Structural and disorder prediction of wt, FEVR and FEVR-6Ala tail 
(C: coil; H: helix; D: disordered region; – : ordered region) and cartoon 
representation of the predicted structure. Residues contributing to the 
loop of FEVR tail are shown in ball and sticks. b) Superposition of 
structural predictions of wt tail (cartoon blue), FEVR tail (cartoon 
yellow) and FEVR-6Ala tail (cartoon magenta). Gray line represent the 
seventh transmembrane segment of the Fz4 protein; c) Superposition of 
CD spectra of wt tail (red line), FEVR tail (blue line) and FEVR-6Ala 
tail (green line).  
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4.3 Affinity of Fz4-FEVR tail for membranes 
 
The two predicted helices of the Fz4-FEVR peptide acquire a boomerang shape 
forming a planar angle of around 90° (Ala504-Lys517- Lys530) and a dihiedral 
angle of 23° (Ala504-Lys517-Arg522-Lys530) (Fig. S1a, b). Hydrophobic and 
aromatic residues of the sequence all face the inner side of the boomerang 
making the Fz4-FEVR structure strongly amphipathic (Fig. 6a and Fig. S1c). 
In contrast, a more random distribution of polar and non polar amino acids is 
predicted for the wt tail (Fig. 6a) that on contrary appears non amphipathic. 
While structure based similarity searches indicate structural homology to 
transcription factors, we noticed that Fz4-FEVR tail resembles in shape and 
hydrophobicity the fusion peptide of HA at the pH of fusion [PDB 1IBN (Han 
et al. 2001)] [root mean square (r.m.s.) deviation on alpha carbons 1.075 Å] 
(Fig. S1). The alignment between HA fusion peptide with wt tail gave no or 
partial similarity with higher r.m.s. scores (1.373 Å to wt tail). The boomerang 
shape formed by the two consecutive HA helices (102° planar angle and 17° 
dihiedral angle) (Fig. S1a, b) was shown to be essential to enable the fusion of 
the viral peptide to the membrane and mutation only marginally affecting the 
shape of the fold resulted in peptides with less fusogenic activity (Lai et al. 
2006; Lai and Tamm 2007).  
The topology of the Fz4-FEVR tail and its predicted amphipaticity would 
suggest proximity and even affinity of this region to the bilayer of the cytosolic 
side of the ER in the context of the full lenght Fz4-FEVR protein.  
To test the affinity of the Fz4-FEVR tail for the membranes, the CD spectra of 
the peptides were recorded in presence of a micellar agent, the non ionic 
detergent ANAPOE-C10E6 (Helenius et al. 1979) (Fig. 6b). In the presence of 
micelles, the Θ at 222 and 208nm for the FEVR tail peptide increased  four 
times, proving the peptide has affinity for membranes and that its fold gets 
stabilized by the lipids. The ratio Θ[222nm]/Θ[208nm] is almost unchanged 
suggesting a neutral effect of the micelles on the structure of the peptide. A 
minimal effect was visible when the micellar agent was added to the wt peptide 
suggesting minor propencity of this sequence to interact with the micelles. 
Surprisingly, ANAPOE-C10E6 modified the CD spectrum of Fz4-FEVR-6Ala 
peptide. A clear increase of Θ at 208 and 222nm was recorded and the ratio 
Θ[222nm]/Θ[208nm] went closer to 1 suggesting that despite its flexibility in 
solution, the C-terminal part of the peptide can acquire an alpha-helical fold 
when interacting with membranes (Fig. 6b). 
To further prove interaction of the Fz4-FEVR tail and Fz4-FEVR-6Ala tail 
with membranes, we measured changes in Trp fluorescence intensity and Trp 
fluorescence polarization in the presence of micelles (Fig. 6c). Fz4-FEVR tail 
has one Trp located on helix 1 and two on helix 2. Trp fluorescence was 
measured in the presence of increasing concentration of ANAPOE-C10E6. In 
the presence of the detergent, a 2.2 fold increase in Trp fluorescence was 
measured suggesting a reduction in the number of the quencing water 
molecules around Trp and consistent with an interaction of the peptide with the 
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micelles. The increase in fluorescence is not visible at detergent concentration 
lower than the critical micellar concentration (c.m.c) confirming the need of 
formed micelles for the peptide to interact. Despite its affinity for membrane, a 
lower fluorescence increase was measured for the Fz4-FEVR-6Ala peptide 
above c.m.c. probably because the C-terminal end of the peptide is interacting 
differently with membrane.  
 
Consistently, eight fold increase in Trp fluorescence polarization for Fz4-
FEVR was measured at detergent concentration higher than the c.m.c. (Fig. 
6c), suggesting a reduction in the speed of tumbling of the Trp when immersed 
in the micelles. No increase was measured for the Fz4-FEVR-6Ala mutant 
confirming the different way of insertion of the peptide in the membrane. 
The two consecutive helices of the Fz4-FEVR tail forms a boomerang shape 
similar to the fusion peptide of HA. Fz4-FEVR tail, but not Fz4 wt tail, 
displays affinity for in vitro formed membranes. The helix 2 of Fz4-FEVR tail 
is stabilized by the membranes or, in absence of them, by the loop.  
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Figure 6: FEVR tail has affinity for membranes. a) Surface representation of wt tail, FEVR 
tail and FEVR-6Ala tail. Polar amino acids are indicated in gray, non polar in magenta; b) CD 
spectra of the indicated peptides in presence of micelles (red line). The spectra are 
superimposed with ones in absence of micelles (black line) shown in Fig. 2c; c) Trp 
fluorescence emission of FEVR peptide (red squares), FEVR-6Ala peptide (green triangles) in 
increasing concentration of micellar agent. Buffer and micellar agent fluorescence are shown 
(yellow circles); d) Trp fluorescence polarization of FEVR peptide and FEVR-6Ala peptide in 
increasing concentration of micelles (shown as in c). Critical micellar concentration (c. m. c.) 
is indicated. 
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4.4 Intracellular localization of Fz4-FEVR mutants 
 
We envisaged that the new fold acquired by Fz4-FEVR tail and its affinity for 
membrane could explain Fz4-FEVR aggregation and ER retention.  
Therefore, mutants disturbing shape and hydrophobicity of the tail were 
generated (structural prediction of some of them in Fig. S2) and their effect on 
the stability and intracellular localization of Fz4-FEVR was analysed in 
transfected cells. Constructs were transiently expressed in Huh-7 cells and their 
localization was visualized by confocal immunofluorescence (Fig. 7). 
Truncation of the last seven residues of the tail did not rescue the Fz4-FEVR1-
525 protein that localizes intracellularly in the ER. In contrast, truncation of the 
last 17 (Fz4-FEVR1-515) and 23 (Fz4-FEVR1-509) residues rescued the 
phenotype localizing both receptors on the PM and in the Golgi complex, thus 
suggesting proper intracellular trafficking. The complete removal (Fz4-
FEVR1-498) of the tail did not rescue the phenotype, proving the need of a 
cytosolic tail for the folding of the receptor.  
Fz4-FEVR-6Ala clearly localizes on PM and in the Golgi complex. A partial 
recovery was also visible for mutant with single or double substitutions in the 
region of the tail closer to the helix connecting loop (residues R519 to W524). 
Alanine scanning in this region (Fz4-FEVR-R519A, Fz4-FEVR-K523A and Fz4-
FEVR-W524A) partially rescued the PM localization. Similar results were 
obtained when couple of residues were substituted in the same region (Fz4-
FEVR-R519A-E520A, Fz4-FEVR-E520A-E521A, Fz4-FEVR-E521A-R522A, Fz4-
FEVR-R522A-K523A and Fz4-FEVR-K523A-W524A). Single substitution 
performed outside the loop region did not rescue the localization of the 
receptor (Fz4-FEVR-W514A). The same results were obtained after double 
substitutions at the edge of the R519-W524 region (Fz4-FEVR-K517A-E518A, Fz4-
FEVR-G526A-E527A), that did not rescue the PM localization. 
Disturbing the fold of the FEVR tail rescues the Fz4-FEVR localization at the 
cell surface. Removal of the helix 2, of the loop or affecting the curvature of 
helix-loop-helix conformation determines the export of the mutant receptor 
from the ER. 
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Figure 7: Disturbing the fold of the FEVR tail induces the rescue of 
Fz4-FEVR to the PM. Surface (-Triton) and intracellular (+ Triton) 
localization of Fz4, Fz4-FEVR and the indicated mutants transiently 
expressed in Huh-7 cells. Cartoon representation of FEVR tail with side 
chains in ball and sticks showing the position of some of the amino acids 
mutated in our study.  
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4.5 Intracellular destiny of chimera VSVG-Fz4-FEVR tail  
 
In order to prove that the Fz4-FEVR tail is necessary and sufficient to induce 
misfolding and aggregation of Fz4-FEVR, a chimeric construct composed by 
the ectodomain and the transmembrane of the reporter VSVG glycoprotein 
coded by the ts-045 mutant strain fused to the cytosolic tail either of Fz4-
FEVR or of Fz4 wt were generated (Fig. 8). VSVG ts-045 is a temperature 
sensitive mutant of VSVG that localizes as monomer in the ER at non 
permissive temperature (40° C). When the permissive temperature (32° C) is 
reestablished the protein trimerizes and moves to the PM (Doms et al. 1987).  
Both VSVG-Fz4wt tail and VSVG-Fz4-FEVR tail localizes in the ER at non 
permissive temperature but only VSVG-Fz4wt tail moved to the Golgi after the 
temperature shift (Fig. 8b). Analysed on a glycerol gradient, VSVG-Fz4wt tail 
appears trimeric as expected (Doms et al. 1987) (Fig. 8c) while VSVG-Fz4-
FEVR tail appears monomeric. Despite the different context, Fz4-FEVR tail 
induces ER retention of VSVG. Differently from Fz4-FEVR, the tail does not 
cause aggregation of VSVG but blocks it in a monomeric but not trimerization 
prone fold.   
!"#$%&'()(&*'#+,*-./0
!"#$%&'()(&'#+,'#1(2*-./0
()(&'&#3
!"#0.4'()(&'
'-./0*0566
!"#0.4'()(&'
'#+,7-*-./0
!#0.4'()(&'
'#+,'#1(2*-./0
*89:*,;<=
$5>>.*5-*.0?*#/4@A5*B
'CA/-DE FCA/-DE.
G
H
*89:*,;<=
F*I;>/E*!I<=
!"#$%&'()(&*'#+,*-./0
!"#$%&'()(&'#+,'#1(2*-./0
>DED>5A-A/>5A.44A54.-56
*J40KH5AD0
Figure 8: FEVR tail appended to the reporter molecule VSVG dictates 
ER retention of the chimera by misfolding. a) Surface (-Triton) and 
intracellular (+ Triton) localization of VSVG-Fz4 wt tail and VSVG-Fz4-
FEVR. b) Intracellular distribution of VSVG-Fz4 tail and VSVG-Fz4-
FEVR tail at not permissive temperature (40 °C) and permissive one (32° 
C). c) Oligomeric state of VSVG-Fz4 tail and VSVG-Fz4-FEVR tail 
analyzed on glycerol gradient  
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5. Discussion 
 
Until the early 1990s, a widely, almost exclusively accepted concept of protein 
function was the well-known protein sequence-structure-function paradigm. 
According to this concept, a protein can achieve its biological function only 
upon folding into a unique, structured state, which represents a kinetically 
accessible and an energetically favorable conformation (usually the global 
energy minimum for the whole protein) determined by its amino acid 
sequence. This specific conformation has been referred to as the native state of 
the protein or what we call ordered proteins. However, recent discoveries of 
intrinsically disordered proteins (IDPs) (Dunker and Obradovic 2001) [know 
also as natively disordered, natively unfolded and intrinsically unstructured 
proteins (Weinreb et al. 1996)] have significantly broadened the view of 
scientific community and increased the number of studies about these 
intriguing members of the protein world. 
In contrast to ordered protein regions, ID regions are not characterized by the 
atom equilibrium positions and dihedral angle equilibrium values around which 
the residue spends most of the time. ID regions exist instead as dynamic 
ensembles in which atom positions and backbone Ramachandran angles vary 
significantly over time with no specific equilibrium values. The conformational 
change of ID regions are tipically noncooperative and random. Thus, the view 
of disorder as dynamic ensembles does not exclude the temporary presence of 
local secondary structure that fluctuates in absence of stabilizing forces 
(Radivojac et al. 2007). 
 
Disordered regions of over 30 residues in length are 5- to 15-fold enriched in 
higher eukaryotic proteomes (30%) relative to eubacteria (6%) and archaea 
(2%), respectively (Ward et al. 2004; Oldfield et al. 2005), which is believed to 
reflect the use of disordered domains in higher order eukaryotic signaling 
networks (Minde et al. 2011). 
 
ID regions are often strongly modified by e.g. phosphorylation or acetylation 
that create changes in net charge of the binding region (Dunker et al. 2008). 
Such modifications can fine tune protein-protein interactions and activity of the 
protein complex in regulation, signaling and control pathways (Liu et al. 2006; 
Dahlberg et al. 2009). 
 
IDPs differ from folded proteins by being able to easily adapt their shape to 
external influence.  
In several reported cases, binding of interacting proteins induces (partial) 
folding or secondary structure formation of IDPs (Dyson and Wright 2005; 
Cortese et al. 2008; Marsh et al. 2010) . Thus, disordered domains may provide 
significant binding plasticity. As binding of a disordered protein to a partner 
restricts its dynamics, the interaction will involve an entropic penalty, which 
folded proteins do not pay (Dyson and Wright 2005). 
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Long, unstructured regions are likely more apt to resist the effects of mutations 
than folded proteins. 
It has been proposed several mechanism by which missense mutations can 
dysregulate IDPs function: i) altered protein interaction surface (Azzopardi et 
al. 2008); ii) changes in secondary structure formation (Nimura et al. 1997); iii) 
altered post-translational modifications (Ferrarese et al. 2007); iv) altered 
dynamics of conformational equilibrium (Minde et al. 2011). 
 
5.1 Disorder to order transition in the fold of the Fz4-FEVR cytosolic tail 
 
Here we show that the mutation L501fsX533 induces an unfold to fold 
structural transition in the cytosolic tail of the Fz4 receptor. To our knowledge, 
this is the first example of a transition occurring in an intrinsically disordered 
region [IDRs (Radivojac et al. 2007)] of a mammalian protein experimentally 
analyzed. The effect is deleterious for the folding of the Fz4 protein, its 
intracellular localization and activity. 
 
The L501fsX533 generates a very unusual frameshift mutation. In the mutant 
nucleotidic sequence the first stop codon is encountered 96 nucleotides after 
the deletion, that thus induces a new frame coding for a new 32 amino acids 
long sequence. The ratio between charged, polar and non polar amino acids is 
almost unaltered between wt and FEVR sequence. In contrast, Trp and Phe 
residues are present in higher number in the FEVR tail and increase its 
aromaticity, despite these amino acids rarely result from frameshift mutations 
due to the low degree of degeneration of their codons.  
 
We prove that a sinthetic peptide with the sequence of the Fz4-FEVR tail 
acquires an helical fold in solution. Specific negative peaks at around 208 and 
222nm in the CD spectrum confirmed its alpha helical fold. This is also 
hypothesized by structure prediction servers that suppose for the peptide a 
boomerang shape formed by two consecutive helices connected by a loop. The 
first four amino acids of the wt tail are conserved in the mutant tail and this 
region was already shown to be in an alpha helical conformation (Punchihewa 
et al. 2009). The amino acids following the alpha helix in the wt tail have low 
helical propensity. Pro529 disrupts the propensity of helical formation in the C-
terminal region of the wt tail while the very high percentage of Glu and Lys in 
the corresponding part of the FEVR tail strongly favour the formation of the 
second helical fold.  
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5.2 FEVR tail has affinity for membranes 
 
The helix-loop-helix shape of the FEVR tail would partially resemble the HA 
fusion peptide at the pH of fusion. This aminoacidic region in the sequence of 
HA undergoes a conformational change when the viral protein is in the 
endosomal compartment and has an unfold- to fold transition acquiring a 
boomerang shape similar to the one predicted for FEVR at physiological pH. 
The hydrophobicity of this HA segment was shown essential for the insertion 
of the peptide in the bilayer of the host cell and small deviation of the angle of 
the boomerang was proven to abolish the fusogenic activity. The two helices of 
the FEVR tail are strongly amphipatic due to the presence on the same side of 
the helix of hydrophobic and aromatic residues (Val503, Phe507, Ile510, Trp514 on 
the first helix and Leu525 and Trp529 on the other one). In the wt tail the 
hydrophobicity is less anysotropic and thus the amphipaticity is lost.  
 
We prove in vitro that, differently from the wt, the sinthetic peptide of the Fz4-
FEVR tail has affinity for lipids. Molar ellipticity, Trp fluorescence intensity 
and Trp fluorescence polarization of the FEVR tail increases in the presence of 
in vitro formed micelles. The reduction of the tumbling speed of the Trp when 
immersed in the micelles is in favour of an high affinity of the FEVR peptide 
for the hydrophobic environment present in the micelles. However, the charged 
residues on the peptide would exclude the FEVR tail be immersed completely 
in the bilayer of the Endoplasmic Reticulum. Moreover, transmembrane 
segments prediction software excludes the possibility that the FEVR tail would 
constitute an extra transmembrane of the receptor due to the highly charged 
Arg and Lys residues in the FEVR tail and supports the model of  a peripheric 
interaction of the FEVR tail with the membrane.  
Intriguing is the effect of the micelles on the FEVR-6Ala tail mutant. CD 
spectra indicate a structuring effect of the lipids on the peptide. Helices of 
FEVR-6Ala tail are probably unstable as seen by the CD spectrum of the 
peptide in absence of micelles (Fig. 2c) and get stabilized only by the presence 
of the detergent. In the FEVR tail the stabilizing effect on the helices is 
probably coming from the loop that allows long distance aromatic contact and 
Vanderwaals interaction. The lipids enforce the stability of the fold 
contributing with the hydrophobic interactions. Both helices get stabilized by 
the micelles. 
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5.3 Affecting the shape of the FEVR tail rescues Fz4, moving the receptor 
to the Plasma Membrane  
 
The need of the helix-loop-helix conformation for inducing the phenotype of 
Fz4-FEVR receptor was confirmed in transfected cells. When a Fz4-FEVR 
mutant missing the second helix was expressed in Huh-7 cells the receptor 
moved to the PM confirming the need of the second helical element.  The same 
rescue effect was seen for mutants missing the loop confirming the need of the 
complete boomerang fold. 
 
Six amino acids would form the kinked loop connecting the two helices in the 
FEVR fold. It is not possible to prove the presence and geometry of the loop in 
vivo but we proved that the sequence of the loop is essential for the Fz4-FEVR 
phenotype. When a synthetic peptide with six Ala residues substituting the 
sequence of the loop was analyzed by CD, its alpha-helical extent was reduced 
and it appears less structured. When a Fz4-FEVR mutant containing the above-
mentioned substitution was expressed in vivo, the phenotype was rescued 
confirming the need of a structured tail for the FEVR induced effect on Fz4 
receptor. The same rescue effect was seen for single or double substitution in 
this region of the FEVR tail. Different shape is predicted for the mutants (Fig. 
S2). In vivo, the PM localization of the mutants perfectly correlate with their 
structural divergence from the Fz4-FEVR. This was already shown for HA 
fusion peptide where single mutation in its sequence alters the fusogenic 
activity and affects infectivity of the virus.  
Thus we hypothesize that the loop of the FEVR tail reduces the flexibility, 
stabilizes the boomerang fold of the tail favouring the interaction between the 
helix 1 and 2 and dictating the phenotype. This fold is a prerequisite for 
dictating the phenotype of the receptor. 
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5.4 Effect of the FEVR tail on in vivo folding of Fz4 and VSVG 
 
We here hypothesize that the FEVR tail is interacting with the cytosolic side of 
the ER membrane, hampering the correct folding of Fz4 (Fig. 6a, b). This is 
likely to happend in vivo because topologically, the tail is in close proximity 
with the ER bilayer, in vivo. The rigidity conferred to the cytoplasmic tail 
could reduce conformational freedom in the transmembrane segment of the 
Fz4 receptor. It was already shown that deletion of two amino acids in the last 
transmembrane of Fz4 (ΔMet493Trp494) traps Fz4 in the ER and induces 
FEVR (Robitaille et al. 2002) suggesting the importance of the last 
transmembrane for a correct folding of Fz4. Our hypothesis could also explain 
the effect that we see of the FEVR tail in the context of the VSVG chimera 
(Fig. 9). As shown by the sedimentation profile, VSVG-Fz4-FEVR tail is 
trapped in a pre-trimeric state. The trimerization of VSVG is dependent by the 
ectodomain and not by the cytosolic tail. This is supporting a model where the 
orientation of the transmembrane of VSVG is altered by the cytosolic FEVR 
tail, and affects the proper interaction of the ectodomains of the glycoprotein 
probably by misalignment.    
a  
Figure 9: a) Schematic cartoon showing the proposed effect of the 
FEVR tail on the folding  of the Fz4 and VSVG protein. 
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5.5 Considerations and Future Plans 
    
 
We show that Fz4-FEVR tail acquires a helix-loop-helix conformation using in 
silico, in vitro and in vivo techniques and proving the new mutated fold being 
responsible for Fz4-FEVR aggregation. The two helices of the FEVR peptide 
are visible by CD, that on contrary is not able to give a clear indication of the 
existence of the interconnecting loop. Thus, a clear proof of its presence in the 
tail of Fz4-FEVR is still missing. An high resolution structure of the peptide in 
the micelles or even better the one of the full Fz4-FEVR receptor would be 
necessary and of great interest. Such structures would prove not only the 
existence of the loop and give geometrical details on its three-dimensional 
structure but they would clearly show the effect of the new tail on the 
misfolding of the full length Fz4-FEVR mutant. 
 
Unfortunately, obtaining crystal structures of small peptides and even more of 
multispan protein cannot be easily achieved and it usually requires a great 
effort in time and money. On one hand the X-ray techniques, despite the 
continuous progress of the field, are struggling in obtaining high resolution 
structure of very flexible and heterogeneous samples like small peptides. On 
the other hand, solving structures of multispan proteins at high-resolution is 
just downing due to the instability of these proteins out of their cellular 
context. Moreover, X-ray crystallography and NMR would require structurally 
homogeneous samples to be successful, while Fz4-FEVR is in an aggregate 
form, that is usually very heterogeneous in its structure.  
 
In the discussion we envisage that the high amphipathicity of the FEVR tail 
would be the reason of its interaction with membranes. We did test the affinity 
of the FEVR peptide for ANAPOE in vitro micelles. 
 
In order to confirm the propensity of the peptide to interact with in vivo derived 
bilayers, we are planning to test its affinity for a crude homogenate of cells. 
This assay will also eventually measure the specificity of the peptide for 
membranes with a particular composition in phospholipids and cholesterol. 
This could for example support the idea of a specific interaction of the mutant 
tail with the cytosolic side of the ER vs the other ones is existing. On contrary, 
the absence of specificity could suggest a tendency of the tail to interact with 
membranes even upon rescue on PM.  
 
We hope this work will convince that the investigation of the effect of disease-
mutations in disordered domains of other transmembrane receptors must be 
taken in account and it will suggest with the threefold approach we used a 
pipeline of experiments to demonstrate this effect experimentally. Finally, we 
think that the new insights into the mechanism of Fz4-FEVR retention and 
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misfolding could give important contribution to the understanding of the 
molecular basis of the conformational diseases.  
     
Figure S1: Comparison of HA fusion peptide and Fz4-FEVR tail. a) 
Superposition of HA fusion peptide (cartoon representation, blue) and 
FEVR tail (cartoon representation, sand). Planar angles formed by the 
helices are indicated. b) Differents in dihedral angles between HA fusion 
peptide and FEVR tail represented as in a. c) Structure (cartoon with side 
chains in ball and sticks) and surface representation (polar amino acids in 
grey and non-polar in magenta) of FEVR tail and HA fusion peptide. 
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Figure S2: Structural prediction of FEVR tail compared with the ones 
predicted for the indicated mutans (cartoon representation sand). 
  50 
7. Aknowledgments 
 
I would like to express my sincere gratitude to: 
  
Prof. Stefano Bonatti, my supervisor and ideator of the present project. I 
appreciate all his contributions of time, ideas, and funding to make my PhD 
experience productive and stimulating.   
 
Dr. Mariano Stornaiuolo, for helping me in performing the experiments, for 
guiding me with patience and willingness in my first steps as a young structural 
researcher. 
 
Dr. Massimo D’Agostino, for his collaborative work, his helpfulness and   
friendship and for the fun moments spent together in the lab.  
 
Prof. Massimo Mallardo and Dr. Mariagrabriella Caporaso for their helpful 
collaboration and for encouraging me in my down moments.  
 
The full professor Maria Vittoria Barone, to put to use the confocal microscopy  
LSM510 Ziess.  
 
“Young” members of the Bonatti lab: Magda Cannata Serio,  
Ramona Carmelo, Serena Generoso, Adriano Ferraro with whom I spent most 
of my days in these past years, for their smiles and helpfulness.  
  
Members of Quinto-Scala lab: Dr. Annarita Scialdone, Dr. Giuseppe Fiume 
and Dr. Annalisa Rossi for their friendship, their generosity and  for  
all the time we’ve spent together.  
  
Members of the Costanzo-Romano lab for their kindness.  
 
 
 
Funding:  
 
This work was supported by grants from Telethon Italia [grant number  
GGP09029].  
 
 
 
 
 
 
 
 
  51 
8. References 
 
Allan D. 1996. Mapping the lipid distribution in the membranes of BHK 
cells (mini-review). Mol Membr Biol 13: 81-84. 
Amara JF, Cheng SH, Smith AE. 1992. Intracellular protein trafficking 
defects in human disease. Trends Cell Biol 2: 145-149. 
An WG, Schulte TW, Neckers LM. 2000. The heat shock protein 90 
antagonist geldanamycin alters chaperone association with 
p210bcr-abl and v-src proteins before their degradation by the 
proteasome. Cell Growth Differ 11: 355-360. 
Anfinsen CB, Haber E. 1961. Studies on the reduction and re-formation of 
protein disulfide bonds. J Biol Chem 236: 1361-1363. 
Aridor M. 2007. Visiting the ER: the endoplasmic reticulum as a target for 
therapeutics in traffic related diseases. Adv Drug Deliv Rev 59: 759-
781. 
Aridor M, Balch WE. 1999. Integration of endoplasmic reticulum 
signaling in health and disease. Nat Med 5: 745-751. 
Aridor M, Hannan LA. 2000. Traffic jam: a compendium of human 
diseases that affect intracellular transport processes. Traffic 1: 836-
851. 
Aridor M, Weissman J, Bannykh S, Nuoffer C, Balch WE. 1998. Cargo 
selection by the COPII budding machinery during export from the 
ER. J Cell Biol 141: 61-70. 
Arnold K, Kiefer F, Kopp J, Battey JN, Podvinec M, Westbrook JD, 
Berman HM, Bordoli L, Schwede T. 2009. The Protein Model 
Portal. J Struct Funct Genomics 10: 1-8. 
Azzopardi D, Dallosso AR, Eliason K, Hendrickson BC, Jones N, 
Rawstorne E, Colley J, Moskvina V, Frye C, Sampson JR et al. 
2008. Multiple rare nonsynonymous variants in the adenomatous 
polyposis coli gene predispose to colorectal adenomas. Cancer Res 
68: 358-363. 
Ban N, Nissen P, Hansen J, Moore PB, Steitz TA. 2000. The complete 
atomic structure of the large ribosomal subunit at 2.4 A resolution. 
Science 289: 905-920. 
Barik S. 2006. Immunophilins: for the love of proteins. Cell Mol Life Sci 
63: 2889-2900. 
Barlowe C, Orci L, Yeung T, Hosobuchi M, Hamamoto S, Salama N, 
Rexach MF, Ravazzola M, Amherdt M, Schekman R. 1994. COPII: 
a membrane coat formed by Sec proteins that drive vesicle budding 
from the endoplasmic reticulum. Cell 77: 895-907. 
Beckers JM, Rothman JE. 1992. Transport between Golgi cisternae. 
Methods Enzymol 219: 5-12. 
Bi X, Corpina RA, Goldberg J. 2002. Structure of the Sec23/24-Sar1 pre-
budding complex of the COPII vesicle coat. Nature 419: 271-277. 
  52 
Blond-Elguindi S, Cwirla SE, Dower WJ, Lipshutz RJ, Sprang SR, 
Sambrook JF, Gething MJ. 1993. Affinity panning of a library of 
peptides displayed on bacteriophages reveals the binding specificity 
of BiP. Cell 75: 717-728. 
Borgese N, Francolini M, Snapp E. 2006. Endoplasmic reticulum 
architecture: structures in flux. Curr Opin Cell Biol 18: 358-364. 
Cabral CM, Liu Y, Sifers RN. 2001. Dissecting glycoprotein quality 
control in the secretory pathway. Trends Biochem Sci 26: 619-624. 
Calebiro D, de Filippis T, Lucchi S, Covino C, Panigone S, Beck-Peccoz P, 
Dunlap D, Persani L. 2005. Intracellular entrapment of wild-type 
TSH receptor by oligomerization with mutants linked to dominant 
TSH resistance. Hum Mol Genet 14: 2991-3002. 
Cannon KS, Hebert DN, Helenius A. 1996. Glycan-dependent and -
independent association of vesicular stomatitis virus G protein with 
calnexin. J Biol Chem 271: 14280-14284. 
Caramelo JJ, Castro OA, Alonso LG, De Prat-Gay G, Parodi AJ. 2003. 
UDP-Glc:glycoprotein glucosyltransferase recognizes structured 
and solvent accessible hydrophobic patches in molten globule-like 
folding intermediates. Proc Natl Acad Sci U S A 100: 86-91. 
Caramelo JJ, Castro OA, de Prat-Gay G, Parodi AJ. 2004. The 
endoplasmic reticulum glucosyltransferase recognizes nearly native 
glycoprotein folding intermediates. J Biol Chem 279: 46280-46285. 
Cheetham ME, Caplan AJ. 1998. Structure, function and evolution of 
DnaJ: conservation and adaptation of chaperone function. Cell 
Stress Chaperones 3: 28-36. 
Chevet E, Cameron PH, Pelletier MF, Thomas DY, Bergeron JJ. 2001. 
The endoplasmic reticulum: integration of protein folding, quality 
control, signaling and degradation. Curr Opin Struct Biol 11: 120-
124. 
Chevet E, Wong HN, Gerber D, Cochet C, Fazel A, Cameron PH, Gushue 
JN, Thomas DY, Bergeron JJ. 1999. Phosphorylation by CK2 and 
MAPK enhances calnexin association with ribosomes. EMBO J 18: 
3655-3666. 
Chung KT, Shen Y, Hendershot LM. 2002. BAP, a mammalian BiP-
associated protein, is a nucleotide exchange factor that regulates 
the ATPase activity of BiP. J Biol Chem 277: 47557-47563. 
Ciechanover A. 1994. The ubiquitin-proteasome proteolytic pathway. Cell 
79: 13-21. 
Cong F, Schweizer L, Varmus H. 2004. Wnt signals across the plasma 
membrane to activate the beta-catenin pathway by forming 
oligomers containing its receptors, Frizzled and LRP. Development 
131: 5103-5115. 
Connell P, Ballinger CA, Jiang J, Wu Y, Thompson LJ, Hohfeld J, 
Patterson C. 2001. The co-chaperone CHIP regulates protein triage 
decisions mediated by heat-shock proteins. Nat Cell Biol 3: 93-96. 
  53 
Cortese MS, Uversky VN, Dunker AK. 2008. Intrinsic disorder in scaffold 
proteins: getting more from less. Prog Biophys Mol Biol 98: 85-106. 
D'Agostino M, Tornillo G, Caporaso MG, Barone MV, Ghigo E, Bonatti 
S, Mottola G. 2011. Ligand of Numb proteins LNX1p80 and LNX2 
interact with the human glycoprotein CD8alpha and promote its 
ubiquitylation and endocytosis. J Cell Sci 124: 3545-3556. 
Dahlberg CL, Nguyen EZ, Goodlett D, Kimelman D. 2009. Interactions 
between Casein kinase Iepsilon (CKIepsilon) and two substrates 
from disparate signaling pathways reveal mechanisms for 
substrate-kinase specificity. PLoS One 4: e4766. 
De Matteis MA, Luini A. 2008. Exiting the Golgi complex. Nat Rev Mol 
Cell Biol 9: 273-284. 
Delom F, Chevet E. 2006. In vitro mapping of calnexin interaction with 
ribosomes. Biochem Biophys Res Commun 341: 39-44. 
Deprez P, Gautschi M, Helenius A. 2005. More than one glycan is needed 
for ER glucosidase II to allow entry of glycoproteins into the 
calnexin/calreticulin cycle. Mol Cell 19: 183-195. 
Derby MC, Gleeson PA. 2007. New insights into membrane trafficking 
and protein sorting. Int Rev Cytol 261: 47-116. 
Do H, Falcone D, Lin J, Andrews DW, Johnson AE. 1996. The 
cotranslational integration of membrane proteins into the 
phospholipid bilayer is a multistep process. Cell 85: 369-378. 
Doms RW, Keller DS, Helenius A, Balch WE. 1987. Role for adenosine 
triphosphate in regulating the assembly and transport of vesicular 
stomatitis virus G protein trimers. J Cell Biol 105: 1957-1969. 
Dudek J, Greiner M, Muller A, Hendershot LM, Kopsch K, Nastainczyk 
W, Zimmermann R. 2005. ERj1p has a basic role in protein 
biogenesis at the endoplasmic reticulum. Nat Struct Mol Biol 12: 
1008-1014. 
Dunker AK, Obradovic Z. 2001. The protein trinity--linking function and 
disorder. Nat Biotechnol 19: 805-806. 
Dunker AK, Oldfield CJ, Meng J, Romero P, Yang JY, Chen JW, Vacic 
V, Obradovic Z, Uversky VN. 2008. The unfoldomics decade: an 
update on intrinsically disordered proteins. BMC Genomics 9 Suppl 
2: S1. 
Dyson HJ, Wright PE. 2005. Intrinsically unstructured proteins and their 
functions. Nat Rev Mol Cell Biol 6: 197-208. 
Ellis RJ. 2007. Protein misassembly: macromolecular crowding and 
molecular chaperones. Adv Exp Med Biol 594: 1-13. 
Ferrarese A, Marin O, Bustos VH, Venerando A, Antonelli M, Allende JE, 
Pinna LA. 2007. Chemical dissection of the APC Repeat 3 multistep 
phosphorylation by the concerted action of protein kinases CK1 
and GSK3. Biochemistry 46: 11902-11910. 
Fuller W, Cuthbert AW. 2000. Post-translational disruption of the delta 
F508 cystic fibrosis transmembrane conductance regulator 
  54 
(CFTR)-molecular chaperone complex with geldanamycin 
stabilizes delta F508 CFTR in the rabbit reticulocyte lysate. J Biol 
Chem 275: 37462-37468. 
Gangelhoff TA, Mungalachetty PS, Nix JC, Churchill ME. 2009. 
Structural analysis and DNA binding of the HMG domains of the 
human mitochondrial transcription factor A. Nucleic Acids Res 37: 
3153-3164. 
Goasduff T, Cederbaum AI. 2000. CYP2E1 degradation by in vitro 
reconstituted systems: role of the molecular chaperone hsp90. Arch 
Biochem Biophys 379: 321-330. 
Gordon MD, Nusse R. 2006. Wnt signaling: multiple pathways, multiple 
receptors, and multiple transcription factors. J Biol Chem 281: 
22429-22433. 
Gorlich D, Rapoport TA. 1993. Protein translocation into proteoliposomes 
reconstituted from purified components of the endoplasmic 
reticulum membrane. Cell 75: 615-630. 
Gusarova V, Caplan AJ, Brodsky JL, Fisher EA. 2001. Apoprotein B 
degradation is promoted by the molecular chaperones hsp90 and 
hsp70. J Biol Chem 276: 24891-24900. 
Han X, Bushweller JH, Cafiso DS, Tamm LK. 2001. Membrane structure 
and fusion-triggering conformational change of the fusion domain 
from influenza hemagglutinin. Nat Struct Biol 8: 715-720. 
Hebert DN, Bernasconi R, Molinari M. 2010. ERAD substrates: which 
way out? Semin Cell Dev Biol 21: 526-532. 
Hebert DN, Foellmer B, Helenius A. 1995. Glucose trimming and 
reglucosylation determine glycoprotein association with calnexin in 
the endoplasmic reticulum. Cell 81: 425-433. 
Hebert DN, Foellmer B, Helenius A. 1996. Calnexin and calreticulin 
promote folding, delay oligomerization and suppress degradation 
of influenza hemagglutinin in microsomes. EMBO J 15: 2961-2968. 
Heidebrecht T, Fish A, von Castelmur E, Johnson KA, Zaccai G, Borst P, 
Perrakis A. 2012. Binding of the J-binding protein to DNA 
containing glucosylated hmU (base J) or 5-hmC: evidence for a 
rapid conformational change upon DNA binding. J Am Chem Soc 
134: 13357-13365. 
Helenius A, Aebi M. 2004. Roles of N-linked glycans in the endoplasmic 
reticulum. Annu Rev Biochem 73: 1019-1049. 
Helenius A, McCaslin DR, Fries E, Tanford C. 1979. Properties of 
detergents. Methods Enzymol 56: 734-749. 
Hiller MM, Finger A, Schweiger M, Wolf DH. 1996. ER degradation of a 
misfolded luminal protein by the cytosolic ubiquitin-proteasome 
pathway. Science 273: 1725-1728. 
Hirao K, Natsuka Y, Tamura T, Wada I, Morito D, Natsuka S, Romero P, 
Sleno B, Tremblay LO, Herscovics A et al. 2006. EDEM3, a soluble 
EDEM homolog, enhances glycoprotein endoplasmic reticulum-
  55 
associated degradation and mannose trimming. J Biol Chem 281: 
9650-9658. 
Hirota N, Yasuda D, Hashidate T, Yamamoto T, Yamaguchi S, Nagamune 
T, Nagase T, Shimizu T, Nakamura M. 2010. Amino acid residues 
critical for endoplasmic reticulum export and trafficking of 
platelet-activating factor receptor. J Biol Chem 285: 5931-5940. 
Hoff H, Zhang H, Sell C. 2004. Protein degradation via the proteosome. 
Methods Mol Biol 285: 79-92. 
Holmes JL, Sharp SY, Hobbs S, Workman P. 2008. Silencing of HSP90 
cochaperone AHA1 expression decreases client protein activation 
and increases cellular sensitivity to the HSP90 inhibitor 17-
allylamino-17-demethoxygeldanamycin. Cancer Res 68: 1188-1197. 
Hwang C, Sinskey AJ, Lodish HF. 1992. Oxidized redox state of 
glutathione in the endoplasmic reticulum. Science 257: 1496-1502. 
Illing ME, Rajan RS, Bence NF, Kopito RR. 2002. A rhodopsin mutant 
linked to autosomal dominant retinitis pigmentosa is prone to 
aggregate and interacts with the ubiquitin proteasome system. J 
Biol Chem 277: 34150-34160. 
Jensen TJ, Loo MA, Pind S, Williams DB, Goldberg AL, Riordan JR. 
1995. Multiple proteolytic systems, including the proteasome, 
contribute to CFTR processing. Cell 83: 129-135. 
Jiang J, Zhou Y, Zou J, Chen Y, Patel P, Yang JJ, Balog EM. 2010. Site-
specific modification of calmodulin Ca(2)(+) affinity tunes the 
skeletal muscle ryanodine receptor activation profile. Biochem J 
432: 89-99. 
Kabani M, Kelley SS, Morrow MW, Montgomery DL, Sivendran R, Rose 
MD, Gierasch LM, Brodsky JL. 2003. Dependence of endoplasmic 
reticulum-associated degradation on the peptide binding domain 
and concentration of BiP. Mol Biol Cell 14: 3437-3448. 
Kaykas A, Yang-Snyder J, Heroux M, Shah KV, Bouvier M, Moon RT. 
2004. Mutant Frizzled 4 associated with vitreoretinopathy traps 
wild-type Frizzled in the endoplasmic reticulum by 
oligomerization. Nat Cell Biol 6: 52-58. 
Kelly SM, Jess TJ, Price NC. 2005. How to study proteins by circular 
dichroism. Biochim Biophys Acta 1751: 119-139. 
Kettern N, Dreiseidler M, Tawo R, Hohfeld J. 2010. Chaperone-assisted 
degradation: multiple paths to destruction. Biol Chem 391: 481-
489. 
Kim MW, Chelliah Y, Kim SW, Otwinowski Z, Bezprozvanny I. 2009. 
Secondary structure of Huntingtin amino-terminal region. 
Structure 17: 1205-1212. 
Kondo H, Hayashi H, Oshima K, Tahira T, Hayashi K. 2003. Frizzled 4 
gene (FZD4) mutations in patients with familial exudative 
vitreoretinopathy with variable expressivity. Br J Ophthalmol 87: 
1291-1295. 
  56 
Lai AL, Park H, White JM, Tamm LK. 2006. Fusion peptide of influenza 
hemagglutinin requires a fixed angle boomerang structure for 
activity. J Biol Chem 281: 5760-5770. 
Lai AL, Tamm LK. 2007. Locking the kink in the influenza hemagglutinin 
fusion domain structure. J Biol Chem 282: 23946-23956. 
Leach MR, Cohen-Doyle MF, Thomas DY, Williams DB. 2002. 
Localization of the lectin, ERp57 binding, and polypeptide binding 
sites of calnexin and calreticulin. J Biol Chem 277: 29686-29697. 
Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB. 2003. 
Protein disorder prediction: implications for structural proteomics. 
Structure 11: 1453-1459. 
Liu J, Xing Y, Hinds TR, Zheng J, Xu W. 2006. The third 20 amino acid 
repeat is the tightest binding site of APC for beta-catenin. J Mol 
Biol 360: 133-144. 
Loo MA, Jensen TJ, Cui L, Hou Y, Chang XB, Riordan JR. 1998. 
Perturbation of Hsp90 interaction with nascent CFTR prevents its 
maturation and accelerates its degradation by the proteasome. 
EMBO J 17: 6879-6887. 
Lord JM, Davey J, Frigerio L, Roberts LM. 2000. Endoplasmic reticulum-
associated protein degradation. Semin Cell Dev Biol 11: 159-164. 
Luyten A, Mortier E, Van Campenhout C, Taelman V, Degeest G, 
Wuytens G, Lambaerts K, David G, Bellefroid EJ, Zimmermann P. 
2008. The postsynaptic density 95/disc-large/zona occludens protein 
syntenin directly interacts with frizzled 7 and supports 
noncanonical Wnt signaling. Mol Biol Cell 19: 1594-1604. 
Ma L, Wang HY. 2006. Suppression of cyclic GMP-dependent protein 
kinase is essential to the Wnt/cGMP/Ca2+ pathway. J Biol Chem 
281: 30990-31001. 
Mancias JD, Goldberg J. 2008. Structural basis of cargo membrane 
protein discrimination by the human COPII coat machinery. 
EMBO J 27: 2918-2928. 
Mandal AK, Gibney PA, Nillegoda NB, Theodoraki MA, Caplan AJ, 
Morano KA. 2010. Hsp110 chaperones control client fate 
determination in the hsp70-Hsp90 chaperone system. Mol Biol Cell 
21: 1439-1448. 
Mandal AK, Nillegoda NB, Chen JA, Caplan AJ. 2008. Ydj1 protects 
nascent protein kinases from degradation and controls the rate of 
their maturation. Mol Cell Biol 28: 4434-4444. 
Marsh JA, Dancheck B, Ragusa MJ, Allaire M, Forman-Kay JD, Peti W. 
2010. Structural diversity in free and bound states of intrinsically 
disordered protein phosphatase 1 regulators. Structure 18: 1094-
1103. 
Martoglio B, Dobberstein B. 1998. Signal sequences: more than just greasy 
peptides. Trends Cell Biol 8: 410-415. 
  57 
Matlack KE, Mothes W, Rapoport TA. 1998. Protein translocation: tunnel 
vision. Cell 92: 381-390. 
Matlack KE, Walter P. 1995. The 70 carboxyl-terminal amino acids of 
nascent secretory proteins are protected from proteolysis by the 
ribosome and the protein translocation apparatus of the 
endoplasmic reticulum membrane. J Biol Chem 270: 6170-6180. 
McCracken AA, Brodsky JL. 1996. Assembly of ER-associated protein 
degradation in vitro: dependence on cytosol, calnexin, and ATP. J 
Cell Biol 132: 291-298. 
Meacham GC, Patterson C, Zhang W, Younger JM, Cyr DM. 2001. The 
Hsc70 co-chaperone CHIP targets immature CFTR for 
proteasomal degradation. Nat Cell Biol 3: 100-105. 
Michelsen K, Yuan H, Schwappach B. 2005. Hide and run. Arginine-based 
endoplasmic-reticulum-sorting motifs in the assembly of 
heteromultimeric membrane proteins. EMBO Rep 6: 717-722. 
Minde DP, Anvarian Z, Rudiger SG, Maurice MM. 2011. Messing up 
disorder: how do missense mutations in the tumor suppressor 
protein APC lead to cancer? Mol Cancer 10: 101. 
Moskowitz SM, Chmiel JF, Sternen DL, Cheng E, Gibson RL, Marshall 
SG, Cutting GR. 2008. Clinical practice and genetic counseling for 
cystic fibrosis and CFTR-related disorders. Genet Med 10: 851-868. 
Mottola G, Cardinali G, Ceccacci A, Trozzi C, Bartholomew L, Torrisi 
MR, Pedrazzini E, Bonatti S, Migliaccio G. 2002. Hepatitis C virus 
nonstructural proteins are localized in a modified endoplasmic 
reticulum of cells expressing viral subgenomic replicons. Virology 
293: 31-43. 
Nakai K. 2000. Protein sorting signals and prediction of subcellular 
localization. Adv Protein Chem 54: 277-344. 
Nillegoda NB, Theodoraki MA, Mandal AK, Mayo KJ, Ren HY, Sultana 
R, Wu K, Johnson J, Cyr DM, Caplan AJ. 2010. Ubr1 and Ubr2 
function in a quality control pathway for degradation of unfolded 
cytosolic proteins. Mol Biol Cell 21: 2102-2116. 
Nilsson IM, von Heijne G. 1993. Determination of the distance between the 
oligosaccharyltransferase active site and the endoplasmic reticulum 
membrane. J Biol Chem 268: 5798-5801. 
Nimura Y, Furuwatari C, Fujimori M, Fujimori Y, Nakata S, Ito K, Hama 
Y, Shingu K, Adachi W, Ogiso Y et al. 1997. Germline mutations of 
the APC gene in two Japanese adenomatous polyposis patients. Jpn 
J Hum Genet 42: 433-439. 
O'Brien JR, Raynaud C, Croux C, Girbal L, Soucaille P, Lanzilotta WN. 
2004. Insight into the mechanism of the B12-independent glycerol 
dehydratase from Clostridium butyricum: preliminary biochemical 
and structural characterization. Biochemistry 43: 4635-4645. 
  58 
Oda Y, Hosokawa N, Wada I, Nagata K. 2003. EDEM as an acceptor of 
terminally misfolded glycoproteins released from calnexin. Science 
299: 1394-1397. 
Oda Y, Okada T, Yoshida H, Kaufman RJ, Nagata K, Mori K. 2006. 
Derlin-2 and Derlin-3 are regulated by the mammalian unfolded 
protein response and are required for ER-associated degradation. J 
Cell Biol 172: 383-393. 
Oldfield CJ, Cheng Y, Cortese MS, Brown CJ, Uversky VN, Dunker AK. 
2005. Comparing and combining predictors of mostly disordered 
proteins. Biochemistry 44: 1989-2000. 
Olivari S, Cali T, Salo KE, Paganetti P, Ruddock LW, Molinari M. 2006. 
EDEM1 regulates ER-associated degradation by accelerating de-
mannosylation of folding-defective polypeptides and by inhibiting 
their covalent aggregation. Biochem Biophys Res Commun 349: 
1278-1284. 
Olivari S, Galli C, Alanen H, Ruddock L, Molinari M. 2005. A novel 
stress-induced EDEM variant regulating endoplasmic reticulum-
associated glycoprotein degradation. J Biol Chem 280: 2424-2428. 
Olivari S, Molinari M. 2007. Glycoprotein folding and the role of EDEM1, 
EDEM2 and EDEM3 in degradation of folding-defective 
glycoproteins. FEBS Lett 581: 3658-3664. 
Olkkonen VM, Ikonen E. 2000. Genetic defects of intracellular-membrane 
transport. N Engl J Med 343: 1095-1104. 
Olkkonen VM, Ikonen E. 2006. When intracellular logistics fails--genetic 
defects in membrane trafficking. J Cell Sci 119: 5031-5045. 
Parodi AJ. 2000. Role of N-oligosaccharide endoplasmic reticulum 
processing reactions in glycoprotein folding and degradation. 
Biochem J 348 Pt 1: 1-13. 
Pilon M, Schekman R, Romisch K. 1997. Sec61p mediates export of a 
misfolded secretory protein from the endoplasmic reticulum to the 
cytosol for degradation. EMBO J 16: 4540-4548. 
Poulter JA, Ali M, Gilmour DF, Rice A, Kondo H, Hayashi K, Mackey 
DA, Kearns LS, Ruddle JB, Craig JE et al. 2010. Mutations in 
TSPAN12 cause autosomal-dominant familial exudative 
vitreoretinopathy. Am J Hum Genet 86: 248-253. 
Pratt WB, Toft DO. 2003. Regulation of signaling protein function and 
trafficking by the hsp90/hsp70-based chaperone machinery. Exp 
Biol Med (Maywood) 228: 111-133. 
Prodromou C, Roe SM, O'Brien R, Ladbury JE, Piper PW, Pearl LH. 
1997. Identification and structural characterization of the 
ATP/ADP-binding site in the Hsp90 molecular chaperone. Cell 90: 
65-75. 
Prydz K, Dick G, Tveit H. 2008. How many ways through the Golgi maze? 
Traffic 9: 299-304. 
  59 
Punchihewa C, Ferreira AM, Cassell R, Rodrigues P, Fujii N. 2009. 
Sequence requirement and subtype specificity in the high-affinity 
interaction between human frizzled and dishevelled proteins. 
Protein Sci 18: 994-1002. 
Radivojac P, Iakoucheva LM, Oldfield CJ, Obradovic Z, Uversky VN, 
Dunker AK. 2007. Intrinsic disorder and functional proteomics. 
Biophys J 92: 1439-1456. 
Rapoport TA, Jungnickel B, Kutay U. 1996. Protein transport across the 
eukaryotic endoplasmic reticulum and bacterial inner membranes. 
Annu Rev Biochem 65: 271-303. 
Recsei P, Kreiswirth B, O'Reilly M, Schlievert P, Gruss A, Novick RP. 
1986. Regulation of exoprotein gene expression in Staphylococcus 
aureus by agar. Mol Gen Genet 202: 58-61. 
Remenyi A, Lins K, Nissen LJ, Reinbold R, Scholer HR, Wilmanns M. 
2003. Crystal structure of a POU/HMG/DNA ternary complex 
suggests differential assembly of Oct4 and Sox2 on two enhancers. 
Genes Dev 17: 2048-2059. 
Robitaille J, MacDonald ML, Kaykas A, Sheldahl LC, Zeisler J, Dube MP, 
Zhang LH, Singaraja RR, Guernsey DL, Zheng B et al. 2002. 
Mutant frizzled-4 disrupts retinal angiogenesis in familial 
exudative vitreoretinopathy. Nat Genet 32: 326-330. 
Rodriguez J, Esteve P, Weinl C, Ruiz JM, Fermin Y, Trousse F, Dwivedy 
A, Holt C, Bovolenta P. 2005. SFRP1 regulates the growth of 
retinal ganglion cell axons through the Fz2 receptor. Nat Neurosci 
8: 1301-1309. 
Romisch K. 2005. Endoplasmic reticulum-associated degradation. Annu 
Rev Cell Dev Biol 21: 435-456. 
Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J. 2009. ER 
stress in Alzheimer's disease: a novel neuronal trigger for 
inflammation and Alzheimer's pathology. J Neuroinflammation 6: 
41. 
Schrag JD, Bergeron JJ, Li Y, Borisova S, Hahn M, Thomas DY, Cygler 
M. 2001. The Structure of calnexin, an ER chaperone involved in 
quality control of protein folding. Mol Cell 8: 633-644. 
Schroder M, Kaufman RJ. 2005. The mammalian unfolded protein 
response. Annu Rev Biochem 74: 739-789. 
Schulte G, Bryja V. 2007. The Frizzled family of unconventional G-
protein-coupled receptors. Trends Pharmacol Sci 28: 518-525. 
Seaman MN. 2007. Identification of a novel conserved sorting motif 
required for retromer-mediated endosome-to-TGN retrieval. J Cell 
Sci 120: 2378-2389. 
Seifert JR, Mlodzik M. 2007. Frizzled/PCP signalling: a conserved 
mechanism regulating cell polarity and directed motility. Nat Rev 
Genet 8: 126-138. 
  60 
Sekijima Y, Wiseman RL, Matteson J, Hammarstrom P, Miller SR, 
Sawkar AR, Balch WE, Kelly JW. 2005. The biological and 
chemical basis for tissue-selective amyloid disease. Cell 121: 73-85. 
Sevier CS, Kaiser CA. 2002. Formation and transfer of disulphide bonds 
in living cells. Nat Rev Mol Cell Biol 3: 836-847. 
Sevier CS, Kaiser CA. 2006. Conservation and diversity of the cellular 
disulfide bond formation pathways. Antioxid Redox Signal 8: 797-
811. 
Sevier CS, Qu H, Heldman N, Gross E, Fass D, Kaiser CA. 2007. 
Modulation of cellular disulfide-bond formation and the ER redox 
environment by feedback regulation of Ero1. Cell 129: 333-344. 
Shaner L, Morano KA. 2007. All in the family: atypical Hsp70 chaperones 
are conserved modulators of Hsp70 activity. Cell Stress Chaperones 
12: 1-8. 
Sharma Y, Chandani S, Sukhaswami MB, Uma L, Balasubramanian D, 
Fairwell T. 1997. Modified helix-loop-helix motifs of calmodulin--
The influence of the exchange of helical regions on calcium-binding 
affinity. Eur J Biochem 243: 42-48. 
Shen Y, Hendershot LM. 2005. ERdj3, a stress-inducible endoplasmic 
reticulum DnaJ homologue, serves as a cofactor for BiP's 
interactions with unfolded substrates. Mol Biol Cell 16: 40-50. 
Shen Y, Meunier L, Hendershot LM. 2002. Identification and 
characterization of a novel endoplasmic reticulum (ER) DnaJ 
homologue, which stimulates ATPase activity of BiP in vitro and is 
induced by ER stress. J Biol Chem 277: 15947-15956. 
Sims KB. 1993. NDP-Related Retinopathies. 
Slusarski DC, Yang-Snyder J, Busa WB, Moon RT. 1997. Modulation of 
embryonic intracellular Ca2+ signaling by Wnt-5A. Dev Biol 182: 
114-120. 
Standley S, Roche KW, McCallum J, Sans N, Wenthold RJ. 2000. PDZ 
domain suppression of an ER retention signal in NMDA receptor 
NR1 splice variants. Neuron 28: 887-898. 
Staub JJ, Althaus BU, Engler H, Ryff AS, Trabucco P, Marquardt K, 
Burckhardt D, Girard J, Weintraub BD. 1992. Spectrum of 
subclinical and overt hypothyroidism: effect on thyrotropin, 
prolactin, and thyroid reserve, and metabolic impact on peripheral 
target tissues. Am J Med 92: 631-642. 
Stornaiuolo M, Lotti LV, Borgese N, Torrisi MR, Mottola G, Martire G, 
Bonatti S. 2003. KDEL and KKXX retrieval signals appended to 
the same reporter protein determine different trafficking between 
endoplasmic reticulum, intermediate compartment, and Golgi 
complex. Mol Biol Cell 14: 889-902. 
Taipale M, Jarosz DF, Lindquist S. 2010. HSP90 at the hub of protein 
homeostasis: emerging mechanistic insights. Nat Rev Mol Cell Biol 
11: 515-528. 
  61 
Tatu U, Helenius A. 1997. Interactions between newly synthesized 
glycoproteins, calnexin and a network of resident chaperones in the 
endoplasmic reticulum. J Cell Biol 136: 555-565. 
Theodoraki MA, Caplan AJ. 2012. Quality control and fate determination 
of Hsp90 client proteins. Biochim Biophys Acta 1823: 683-688. 
Thomas M, Dadgar N, Aphale A, Harrell JM, Kunkel R, Pratt WB, 
Lieberman AP. 2004. Androgen receptor acetylation site mutations 
cause trafficking defects, misfolding, and aggregation similar to 
expanded glutamine tracts. J Biol Chem 279: 8389-8395. 
Totani K, Ihara Y, Matsuo I, Ito Y. 2006. Substrate specificity analysis of 
endoplasmic reticulum glucosidase II using synthetic high 
mannose-type glycans. J Biol Chem 281: 31502-31508. 
Trepel J, Mollapour M, Giaccone G, Neckers L. 2010. Targeting the 
dynamic HSP90 complex in cancer. Nat Rev Cancer 10: 537-549. 
Tusnady GE, Simon I. 1998. Principles governing amino acid composition 
of integral membrane proteins: application to topology prediction. 
J Mol Biol 283: 489-506. 
van Vliet C, Thomas EC, Merino-Trigo A, Teasdale RD, Gleeson PA. 
2003. Intracellular sorting and transport of proteins. Prog Biophys 
Mol Biol 83: 1-45. 
Walter P, Johnson AE. 1994. Signal sequence recognition and protein 
targeting to the endoplasmic reticulum membrane. Annu Rev Cell 
Biol 10: 87-119. 
Wang X, Venable J, LaPointe P, Hutt DM, Koulov AV, Coppinger J, 
Gurkan C, Kellner W, Matteson J, Plutner H et al. 2006. Hsp90 
cochaperone Aha1 downregulation rescues misfolding of CFTR in 
cystic fibrosis. Cell 127: 803-815. 
Wang Y, Rattner A, Zhou Y, Williams J, Smallwood PM, Nathans J. 2012. 
Norrin/Frizzled4 signaling in retinal vascular development and 
blood brain barrier plasticity. Cell 151: 1332-1344. 
Ward CL, Omura S, Kopito RR. 1995. Degradation of CFTR by the 
ubiquitin-proteasome pathway. Cell 83: 121-127. 
Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT. 2004. Prediction 
and functional analysis of native disorder in proteins from the 
three kingdoms of life. J Mol Biol 337: 635-645. 
Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT, Jr. 1996. 
NACP, a protein implicated in Alzheimer's disease and learning, is 
natively unfolded. Biochemistry 35: 13709-13715. 
Weitzmann A, Volkmer J, Zimmermann R. 2006. The nucleotide exchange 
factor activity of Grp170 may explain the non-lethal phenotype of 
loss of Sil1 function in man and mouse. FEBS Lett 580: 5237-5240. 
Whitesell L, Mimnaugh EG, De Costa B, Myers CE, Neckers LM. 1994. 
Inhibition of heat shock protein HSP90-pp60v-src heteroprotein 
complex formation by benzoquinone ansamycins: essential role for 
  62 
stress proteins in oncogenic transformation. Proc Natl Acad Sci U S 
A 91: 8324-8328. 
Wiertz EJ, Tortorella D, Bogyo M, Yu J, Mothes W, Jones TR, Rapoport 
TA, Ploegh HL. 1996. Sec61-mediated transfer of a membrane 
protein from the endoplasmic reticulum to the proteasome for 
destruction. Nature 384: 432-438. 
Williams DB. 2006. Beyond lectins: the calnexin/calreticulin chaperone 
system of the endoplasmic reticulum. J Cell Sci 119: 615-623. 
Wong HC, Mao J, Nguyen JT, Srinivas S, Zhang W, Liu B, Li L, Wu D, 
Zheng J. 2000. Structural basis of the recognition of the dishevelled 
DEP domain in the Wnt signaling pathway. Nat Struct Biol 7: 1178-
1184. 
Xu Q, Wang Y, Dabdoub A, Smallwood PM, Williams J, Woods C, Kelley 
MW, Jiang L, Tasman W, Zhang K et al. 2004. Vascular 
development in the retina and inner ear: control by Norrin and 
Frizzled-4, a high-affinity ligand-receptor pair. Cell 116: 883-895. 
Xu Z, Devlin KI, Ford MG, Nix JC, Qin J, Misra S. 2006. Structure and 
interactions of the helical and U-box domains of CHIP, the C 
terminus of HSP70 interacting protein. Biochemistry 45: 4749-4759. 
Yamamoto A, Nagano T, Takehara S, Hibi M, Aizawa S. 2005. Shisa 
promotes head formation through the inhibition of receptor protein 
maturation for the caudalizing factors, Wnt and FGF. Cell 120: 
223-235. 
Ye X, Wang Y, Cahill H, Yu M, Badea TC, Smallwood PM, Peachey NS, 
Nathans J. 2009. Norrin, frizzled-4, and Lrp5 signaling in 
endothelial cells controls a genetic program for retinal 
vascularization. Cell 139: 285-298. 
Younger JM, Chen L, Ren HY, Rosser MF, Turnbull EL, Fan CY, 
Patterson C, Cyr DM. 2006. Sequential quality-control checkpoints 
triage misfolded cystic fibrosis transmembrane conductance 
regulator. Cell 126: 571-582. 
Zhang Y. 2008. I-TASSER server for protein 3D structure prediction. 
BMC Bioinformatics 9: 40. 
Zou J, Guo Y, Guettouche T, Smith DF, Voellmy R. 1998. Repression of 
heat shock transcription factor HSF1 activation by HSP90 (HSP90 
complex) that forms a stress-sensitive complex with HSF1. Cell 94: 
471-480. 
  
